Skip to main content

Flux Power Holdings Inc

For the period ended Jun 30, 2024. Filed Jan 29, 2025.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Jan 29, 2025

FLUX$0.34-6.8%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Notes to the Consolidated Financial Statements

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2024 and JUNE 30, 2023

NOTE 1 –NATURE OF BUSINESS

Nature of Business

Flux Power Holdings, Inc. (“Flux”) was incorporated in 2008 in the State of Nevada, and Flux’s operations are conducted through its wholly owned subsidiary, Flux Power, Inc. (“Flux Power”), a California corporation (collectively, the “Company”).

The Company designs, develops, manufactures, and sells a portfolio of advanced lithium-ion energy storage solutions for electrification of a range of industrial commercial sectors which include material handling, airport ground support equipment (“GSE”), and stationary energy storage. The Company believes its mobile and stationary energy storage solutions provide customers with a reliable, high performing, cost effective, and more environmentally friendly alternative as compared to traditional lead acid and propane-based solutions. The Company’s modular and scalable design allows different configurations of lithium-ion energy storage solutions to be paired with our proprietary wireless battery management system to provide the level of energy storage required and “state of the art” real time monitoring of pack performance. The Company believes that the increasing demand for lithium-ion energy storage solutions and more environmentally friendly energy storage solutions in the material handling sector should continue to drive revenue growth.

NOTE 2 –Restatement of Previously Issued Financial Statements

In connection with the preparation of its consolidated financial statements as of and for the year ended June 30, 2024, the Company identified multiple prior-period misstatements. In accordance with Staff Accounting Bulletins No. 99 (“SAB No. 99”) Topic 1.M, “Materiality” and SAB No. 99 Topic 1.N “Considering the Effects of Misstatements when Quantifying Misstatements in the Current Year Financial Statements,” the Company assessed the materiality of these misstatements to its previously issued consolidated financial statements. Based upon the Company’s evaluation of both quantitative and qualitative factors, the Company concluded the misstatements were material to the Company’s previously issued consolidated financial statements for the fiscal years ended June 30, 2023 and 2022. Accordingly, the Company is restating its previously issued audited consolidated financial statements and related notes as of and for the fiscal years ended June 30, 2023 and 2022. See Note 15 – Restatement of Previously Issued Financial Statements for the effects of the restatement as of and for the fiscal years ended June 30, 2023 and 2022 and the restated amounts reflected within Note 4 – Inventories, Note 11 – Income Taxes and Note 12 – Concentrations. See Note 16 – Quarterly Financial Summary (Unaudited) for the effects of the restatement on the interim periods within the fiscal years ended June 30, 2024, 2023 and 2022

NOTE 3 –SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

A summary of the Company’s significant accounting policies which have been consistently applied in the preparation of the accompanying consolidated financial statements follows:

Principles of Consolidation

The consolidated financial statements include Flux Power Holdings, Inc. and its wholly-owned subsidiary Flux Power, Inc. after elimination of all intercompany accounts and transactions.

Liquidity and Financial Condition

The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. However, substantial doubt about the Company’s ability to continue as a going concern exists.

Historically, the Company’s revenues and operating cash flows have not been sufficient to sustain its operations and the Company has relied on debt and equity financing for additional funds. The Company has incurred an accumulated deficit of $99.7 million through June 30, 2024, and for the year ended June 30, 2024 generated negative cash flows from operations of $4.8 million and incurred a net loss of $8.3 million. As of December 31, 2024, the Company had a cash balance of $1.0 million, $6.3 million available funding under the Gibraltar Business Capital (“GBC”) Credit Facility, and $1.0 million available for future draws under the Subordinated LOC.

In addition, the Company’s operations have been impacted by delays in new orders of its energy storage solutions due to corresponding deferrals of new forklift purchases mainly caused by lower capital spending in the market sector that the Company serves and interest rate variability affecting selected large customer fleets which have impacted the Company’s ability to meet projected revenue targets and generate cash from operations.

Management has evaluated the Company’s expected cash requirements, including investments in additional sales and marketing and research and development, capital expenditures and working capital requirements, and believes the Company’s existing cash and funding available under the GBC Credit Facility and the Subordinated LOC, along with the forecasted gross margin, will not be sufficient to meet the Company’s anticipated capital resources to fund planned operations for the next twelve months following the filing date of this Annual Report on Form 10-K.

Management is evaluating strategies to improve profitability of operations and to obtain additional funding. These steps include actual and planned price increases for our energy storage solutions, a number of cost saving initiatives including product cost efficiencies and planned operating cost savings. Based on the Company’s existing backlog and customer orders, management anticipates increased revenues, together with the improvements in its gross margin will move it closer to profitability. The planned gross margin improvement tasks include, but are not limited to, a plan to drive bill of material costs down while increasing price of our products for new orders. We also continue to execute our cost reduction, sourcing, and pricing recovery initiatives in efforts to increase our gross margins and improve cash flow from operations. Unforeseen factors in the general economy beyond management’s control could potentially have negative impact on the planned gross margin improvement plan. Management is continuing to evaluate other sources of capital to fund its operations and growth. However, there can be no assurance that the Company will be able to realize the plans for improved operations or access necessary additional financing when needed to provide sufficient liquidity to continue its operations over the next twelve months. If such liquidity is not available when required, management will be required to curtail investments in new product development, which may have a material adverse effect on future cash flows and results of operations and the Company’s ability to continue operating as a going concern.

The accompanying consolidated financial statements do not include any adjustments that would be necessary should the Company be unable to continue as a going concern and, therefore, be required to liquidate its assets and discharge its liabilities in other than the normal course of business and at amounts that may differ from those reflected in the accompanying consolidated financial statements.

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, and expenses, as well as certain financial statement disclosures. Significant estimates include valuation allowances relating to inventory and deferred tax assets. While management believes that the estimates and assumptions used in the preparation of the financial statements are appropriate, actual results could differ from these estimates.

Cash and Cash Equivalents

As of June 30, 2024, 2023 and 2022, cash was approximately $0.6 million, $2.4 million and $0.5 million, respectively. Cash consisted of funds held in a non-interest-bearing bank deposit account. The Company considers all liquid short-term investments with maturities of less than three months when acquired to be cash equivalents. The Company hadno cash equivalents at June 30, 2024, 2023 and 2022.

Fair Values of Financial Instruments

The carrying amount of our cash, accounts payable, accounts receivable, and accrued liabilities approximate their estimated fair values due to the short-term maturities of those financial instruments. The carrying amount of the line of credit agreement approximates its fair values as interest approximates current market interest rates for similar instruments. Management has concluded that it is not practical to determine the estimated fair value of amounts due to related parties because the transactions cannot be assumed to have been consummated at arm’s length, the terms are not deemed to be market terms, there are no quoted values available for these instruments, and an independent valuation would not be practical due to the lack of data regarding similar instruments, if any, and the associated potential costs.

The Company does not have any other assets or liabilities that are measured at fair value on a recurring or non-recurring basis.

Accounts Receivable

Accounts receivable are carried at their estimated collectible amounts. The Company has not experienced significant issues related to the collection of its accounts receivable. As of June 30, 2024, the company has an allowance for credit losses of $55,000. The company didnot record an allowance for credit losses during the years ended June 30, 2023 and 2022.

Inventories

Inventories consist primarily of battery management systems and the related subcomponents and are stated at the lower of cost (first-in, first-out) or net realizable value. The Company evaluates inventories to determine if write-downs are necessary due to obsolescence or if the inventory levels are in excess of anticipated demand at market value based on consideration of historical sales and product development plans. The Company recorded an adjustment related to obsolete inventory in the amount of approximately $490,000, $690,000 and $665,000 during the years ended June 30, 2024, 2023 (as restated) and 2022 (as restated), respectively.

Property, Plant and Equipment

Property, plant and equipment are stated at cost, net of accumulated depreciation. Depreciation and amortization are provided using the straight-line method over the estimated useful lives, of the related assets ranging from three tofive years, or, in the case of leasehold improvements, over the lesser of the useful life of the related asset or the lease term.

Stock-based Compensation

Pursuant to the provisions of the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic No. 718-10,Compensation-Stock Compensation, which establishes accounting for equity instruments exchanged for employee service, we utilize the Black-Scholes option pricing model to estimate the fair value of employee stock option awards at the date of grant, which requires the input of highly subjective assumptions, including expected volatility and expected life. Changes in these inputs and assumptions can materially affect the measure of estimated fair value of our share-based compensation. These assumptions are subjective and generally require significant analysis and judgment to develop. When estimating fair value, some of the assumptions will be based on, or determined from, external data and other assumptions may be derived from our historical experience with stock-based payment arrangements. The appropriate weight to place on historical experience is a matter of judgment, based on relevant facts and circumstances.

Common stock or equity instruments such as warrants issued for services to non-employees are valued at their estimated fair value at the measurement date (the date when a firm commitment for performance of the services is reached, typically the date of issuance, or when performance is complete). If the total value exceeds the par value of the stock issued, the value in excess of the par value is added to the additional paid-in-capital.

Revenue Recognition

The Company recognizes revenue in accordance to the ASC Topic 606,Revenue from Contracts with Customers (“ASC 606”) for all contracts. The Company derives its revenue from the sale of products to customers. The Company sells its products primarily through a distribution network of equipment dealers, OEMs and battery distributors in primarily North America. The Company recognizes revenue for the products when all significant risks and rewards have been transferred to the customer, there is no continuing managerial involvement associated with ownership of the goods sold is retained, no effective control over the goods sold is retained, the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transactions will flow to the Company and the costs incurred or to be incurred with respect to the transaction can be measured reliably.

Product revenue is recognized as a distinct single performance obligation which for the Company’s three major customers represents the point in time that they receive delivery of the products, and for all other customers represents the point in time that the Company ships the products. Our customers do have a right to return product but our returns have historically been minimal.

Product Warranties

The Company evaluates its exposure to product warranty obligations based on historical experience. Our products, primarily lift equipment packs, are warrantied for five years unless modified by a separate agreement. As of June 30, 2024, 2023 and 2022, the Company carried warranty liability of approximately $3,018,000, $1,600,000 and $1,012,000, respectively, which is included in accrued expenses on the Company’s consolidated balance sheets.

Impairment of Long-lived Assets

In accordance with authoritative guidance for the impairment or disposal of long-lived assets, if indicators of impairment exist, the Company assesses the recoverability of the affected long-lived assets by determining whether the carrying value of such assets can be recovered through the undiscounted future operating cash flows.

If impairment is indicated, the Company measures the amount of such impairment by comparing the carrying value of the asset to the present value of the expected future cash flows associated with the use of the asset. The Company believes that no impairment indicators were present, and accordinglyno impairment losses were recognized during the fiscal years ended June 30, 2024, 2023 and 2022.

The Company is actively engaged in new product development efforts. Research and development costs relating to possible future products are expensed as incurred.

Income Taxes

Pursuant to FASB ASC Topic No. 740,Income Taxes, deferred tax assets or liabilities are recorded to reflect the future tax consequences of temporary differences between the financial reporting basis of assets and liabilities and their tax basis at each year-end. These amounts are adjusted, as appropriate, to reflect enacted changes in tax rates expected to be in effect when the temporary differences reverse. The Company has analyzed filing positions in all of the federal and state jurisdictions where the Company is required to file income tax returns, as well as all open tax years in these jurisdictions. As a result, no unrecognized tax benefits have been identified as of June 30, 2024, 2023 or 2022 and, accordingly, no additional tax liabilities have been recorded.

The Company records deferred tax assets and liabilities based on the differences between the financial statement and tax bases of assets and liabilities and on operating loss carry forwards using enacted tax rates in effect for the year in which the differences are expected to reverse. A valuation allowance is provided when it is more likely than not that some portion or all of a deferred tax asset will not be realized.

Net Loss Per Common Share

The Company calculates basic loss per common share by dividing net loss by the weighted average number of common shares outstanding during the periods. Diluted loss per common share includes the impact from all dilutive potential common shares relating to outstanding convertible securities.

For the fiscal years ended June 30, 2024, 2023 and 2022, basic and diluted weighted-average common shares outstanding were 16,548,533,16,055,256 and 15,439,530, respectively. The Company incurred a net loss for the fiscal years ended June 30, 2024, 2023 and 2022, and therefore, basic and diluted loss per share for each fiscal year were the same because potential common share equivalents would have been anti-dilutive. The potentially dilutive common shares outstanding at June 30, 2024, 2023 and 2022 that were excluded from diluted weighted-average common shares outstanding represent shares underlying outstanding stock options, RSUs and warrants, as follows:

Year ended June 30,
202420232022
Stock options1,605,060973,400503,433
RSUs114,666193,749304,221
Warrants1,413,1101,455,1191,455,119
Antidilutive securities3,132,8362,622,2682,262,773

Adopted Accounting Pronouncements

The Company did not adopt any new accounting pronouncements during the year ended June 30, 2024.

Recently Issued Accounting Pronouncements

In December 2023, the FASB issued Accounting Standards Update (“ASU”) 2023-09,Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which requires more detailed income tax disclosures. The guidance requires entities to disclose disaggregated information about their effective tax rate reconciliation as well as expanded information on income taxes paid by jurisdiction. The disclosure requirements will be applied on a prospective basis, with the option to apply them retrospectively. The standard is effective for our fiscal year ending June 30, 2026, with early adoption permitted. The Company is evaluating the disclosure requirements related to the new standard.

In November 2023, the FASB issued ASU 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures”, which expands annual and interim disclosure requirements for reportable segments, primarily through enhanced disclosures about significant segment expenses. The standard is effective annually for our fiscal year ending June 30, 2025 and interim periods thereafter. Early adoption is permitted. The Company is evaluating the disclosure requirements related to the new standard.

NOTE 4 –INVENTORIES

Inventories consist of the following:

June 30,
202420232022
Restated · Restated
Raw materials$12,850,000$11,507,000$11,495,000
Work in process474,0001,277,000927,000
Finished goods3,653,0003,374,0002,018,000
Total Inventories$16,977,000$16,158,000$14,440,000

Inventories consist primarily of our energy storage systems and the related subcomponents, and are stated at the lower of cost or net realizable value.

NOTE 5 –OTHER CURRENT ASSETS

Other current assets consist of the following:

June 30,
202420232022
Prepaid insurance$419,000$573,000$478,000
Prepaid expenses181,000202,000343,000
Other345,000143,000440,000
Total other current assets$945,000$918,000$1,261,000

NOTE 6 –ACCRUED EXPENSES

Accrued expenses consist of the following:

June 30,
202420232022
Payroll and bonus accrual$471,000$1,157,000$767,000
PTO accrual437,000412,000430,000
Warranty liability3,018,0001,600,0001,012,000
Other-12,000-
Total accrued expenses$3,926,000$3,181,000$2,209,000

NOTE 7 –PROPERTY, PLANT AND EQUIPMENT, NET

Property, plant and equipment, net consist of the following:

June 30,
202420232022
Machinery and equipment$1,352,000$1,169,000$808,000
Office equipment2,690,0002,153,0001,574,000
Furniture and equipment274,000273,000256,000
Vehicles--20,000
Leasehold improvements148,00081,00056,000
CIP106,00043,000-
Property, plant and equipment, gross4,570,0003,719,0002,714,000
Less: accumulated depreciation(2,821,000)(1,930,000)(1,136,000)
Total property, plant and equipment, net$1,749,000$1,789,000$1,578,000

Depreciation expense was approximately $1,045,000, $899,000 and $575,000, for the fiscal years ended June 30, 2024, 2023 and 2022, respectively, and is included in selling and administrative expenses in the accompanying consolidated statements of operations.

NOTE 8 –NOTES PAYABLE

Revolving Line of Credit

Gibraltar Business Capital Credit Facility

On July 28, 2023, the Company entered into a Loan and Security Agreement (the “Agreement”) with GBC. The Agreement provides the Company with a senior secured revolving loan facility for up to $15.0 million (the “Revolving Loan Commitment”). The revolving amount available under the GBC Credit Facility is equal to the lesser of the Revolving Loan Commitment and the borrowing base amount (as defined in the Agreement). The GBC Credit Facility is evidenced by a revolving note, which matures on July 28, 2025 (the “Maturity Date”), unless extended, modified or renewed (the “Revolving Note”). Provided that there is no event of default, the Maturity Date can automatically be extended for one (1) year period upon payment of a renewal fee for each such extension in the amount of three-quarters of one percent (0.75%) of the Revolving Loan Commitment, which fee will be due and payable on or before the applicable Maturity Date.

In addition, subject to conditions and terms set forth in the Agreement, the Company may request an increase in the Revolving Loan Commitment from time to time upon not less than 30 days’ notice to GBC which increase may be made at the sole discretion of GBC, as long as: (a) the requested increase is in a minimum amount of $1,000,000, and (b) the total increases do not exceed $5,000,000 and no more than five (5) increases are made. Outstanding principal under the GBC Credit Facility accrues interest at Secured Overnight Financing Rate (“SOFR”, as defined in the Agreement) plus five and one half of one percent (5.50%) per annum with such interest payment due monthly on the last day of the month. In the event of default, the amounts due under the Agreement bear interest at a rate per annum equal to three percent (3.0%) above the rate that is otherwise applicable to such amounts. The Company paid GBC a non-refundable closing fee for the GBC Credit Facility of $112,500 upon the execution of the Agreement. In addition, the Company is required to pay a monthly unused line fee equal to one-half of one percent (0.50%) per annum on the difference between the Revolving Loan Commitment and the average outstanding principal balance of the revolving loan(s) for such month. The obligations under the GBC Credit Facility may be prepaid in whole or in part at any time upon an exit fee of (a) two percent (2.00%) of the Revolving Loan Commitment if the obligations are paid in full during the first year after the closing date, or (b) one percent (1.00%) of the Revolving Loan Commitment if the obligations are paid in full one year after the closing date, provided, that, the exit fee will be waived if such prepayment occurs in connection with the refinancing of the obligations with Bank of America, N.A., as lender.

On November 2, 2023, the Company entered into the First Amendment to Loan and Security Agreement (the “First Amendment”) with Gibraltar Business Capital, LLC (“GBC”), which amended certain definition of the Subordinated Debt referenced in the Loan and Security Agreement dated July 28, 2023 as Subordinated Debt owed by Borrower to Cleveland Capital L.P. pursuant to that certain Subordinated Unsecured Promissory Note, dated as of November 1, 2023, in the aggregate principal amount of $2,000,000.

On January 30, 2024, the Company entered into the Second Amendment to Loan and Security Agreement (the “Second Amendment”) with GBC, which amended certain terms of the Loan and Security Agreement dated July 28, 2023, including but not limited to, (i) increasing the commitment amount from $15.0 million to $16.0 million, (ii) adding an additional non-refundable closing fee in the amount of $7,500 in cash for the increase in the commitment amount to $16 million, (iii) amending the definition of “Eligible Accounts;” and (iv) amending the EBITDA Minimum financial covenant of the Company. In consideration for the Second Amendment, the Company agreed to pay GBC a non-refundable amendment fee of $10,000 in cash, in addition to the $7,500 non-refundable closing fee paid.

The loans and other obligations of the Company under the GBC Credit Facility are secured by substantially all of the tangible and intangible assets of the Company (including, without limitation, intellectual property) pursuant to the terms of the Agreement and the Intellectual Property Security Agreement entered into by and among the Company and GBC on July 28, 2023. During the year ended June 30, 2024, the Company had multiple drawdowns under the GBC Credit Facility totaling $65.8 million, inclusive of the full repayment of the SVB Credit Facility, and made multiple repayments totaling $52.0 million. As of June 30, 2024, the outstanding balance under the GBC Credit Facility was approximately $13.8 million, with up to $2.2 million available for future borrowings, subject to borrowing base limitations.

In April 2024, the Company notified GBC of a certain event of default with respect to the Company’s anticipated failure to maintain the EBITDA covenant for the trailing three (3) month period ended April 30, 2024, or Default. On May 8, 2024, the Company received a Waiver, which waived the Default, subject to satisfaction of the following conditions: (i) receipt of a counterpart of the Waiver duly executed by the Company; (ii) receipt of the waiver fee of $20,000; (iii) receipt of the representations and warranties from the Company that after giving effect to the Waiver, the representations and warranties contained in the Agreement, the Waiver and the other Loan Documents shall be true and correct; and (iv) after giving effect to the Waiver, no additional event of default shall have occurred and be continuing on and as of the effective date of the Waiver.

On May 31, 2024, the Company entered into the Third Amendment to Loan and Security Agreement (the “Third Amendment”) with GBC which amended certain terms of the Loan and Security Agreement dated July 28, 2023, including but not limited to amending the EBITDA Minimum financial covenant of the Company. In consideration for the Third Amendment, the Company agreed to pay GBC a non-refundable amendment fee of $50,000 in cash.

Silicon Valley Bank Credit Facility

On November 9, 2020, the Company entered into a Loan and Security Agreement (“Loan and Security Agreement”) with Silicon Valley Bank (“SVB”).

On October 29, 2021, the Company entered into a First Amendment to Loan and Security Agreement (“First Amendment” and together with the Agreement, the “Loan Agreement”) with SVB which amended certain terms of the Agreement including, but not limited to, increasing the amount of the revolving line of credit from $4.0 million to $6.0 million, and extending the maturity date to November 7, 2022. The First Amendment provided the Company with a senior secured credit facility for up to $6.0 million available on a revolving basis (“Revolving LOC”). Outstanding principal under the Revolving LOC accrued interest at a floating rate per annum equal to the greater of(i) Prime Rate plus two and a half percent (2.50%), or (ii) five and three-quarters percent (5.75%). The Company paid a non-refundable commitment fee of $15,000 upon execution of the Agreement and an additional non-refundable commitment fee of $22,500 in connection with the First Amendment.

On June 23, 2022, the Company entered into a Second Amendment to Loan and Security Agreement (“Second Amendment” and together with the Loan Agreement, the “Second Amended Loan Agreement”) with SVB, which amended certain terms of the Loan Agreement, including but not limited to, (i) increasing the amount of the revolving line of credit to $8.0 million, (ii) changing the financial covenants of the Company from one based on tangible net worth to another based on adjusted EBITDA (as defined in the Second Amendment) on a trailing six (6) month basis and liquidity ratio certified as of the end of each month pursuant to the calculations set forth therein, and (iii) allowing for the assignment and transfer by SVB of all of its obligations, rights and benefits under the Agreement and Loan Documents (as defined in the Agreement and except for the Warrants).

In addition, under the Second Amendment, the interest rate terms for the outstanding principal under the Revolving LOC were amended to accrue interest at a floating per annum rate equal to the greater of either(A) Prime Rate plus three and one-half of one percent (3.50%) or (B) seven and one-half of one percent (7.50%). Interest payments are due monthly on the last day of the month. In addition, the Company is required to pay a quarterly unused facility fee equal to one-quarter of one percent (0.25%) per annum of the average daily unused portion of the $8.0 million commitment under the SVB Credit Facility, depending upon availability of borrowings under the Revolving LOC. Pursuant to the Second Amendment, the Company paid SVB a non-refundable amendment fee of $5,000 and SVB’s legal fees and expenses incurred in connection with the Second Amendment.

In connection with the Second Amendment, the Company issued atwelve-year warrant to SVB and its designee, SVB Financial Group, to purchase up to 40,806 shares of common stock of the Company at an exercise price of $2.23 per share pursuant to the terms set forth therein.

On November 7, 2022, the Company entered into a Third Amendment to Loan and Security Agreement (“Third Amendment”) with SVB, which amended certain terms of the Second Amended Loan Agreement (together with the Third Amendment, the “Third Amended Loan Agreement”), including but not limited to, (i) extending the maturity date from November 7, 2022 to May 7, 2023 (the “Extension Period”), (ii) amending the financial covenants of the Company to cover the Extension Period and to include a liquidity ratio financial covenant, and (iii) amending the definition of Permitted Liens (as defined in the Third Amendment). Pursuant to the Third Amendment, the Company paid SVB a non-refundable amendment fee of $12,500 and SVB’s legal fees and expenses incurred in connection with the Third Amendment.

On January 10, 2023, the Company entered into a Fourth Amendment to Loan and Security Agreement (the “Fourth Amendment”) with SVB, which amended certain terms of the Third Amended Loan Agreement including but not limited to, (i) increasing the amount of the SVB Credit Facility from $8.0 million to $14.0 million, (ii) removing the liquidity ratio financial covenant of the Company under Section 6.9 of the Third Amended Loan Agreement, (iii) amending the definition of Borrowing Base (as defined in the Fourth Amendment), which includes a new defined term for Net Orderly Liquidation Value (as defined in the Fourth Amendment), and (iv) removing certain defined liquidity terms under Section 13.1 of the Third Amended Loan Agreement. Pursuant to the Fourth Amendment, the Company paid SVB a non-refundable amendment fee of $10,000 and SVB’s legal fees and expenses incurred in connection with the Fourth Amendment.

On April 27, 2023, the Company entered into a Fifth Amendment to Loan and Security Agreement (the “Fifth Amendment”) with SVB which further amended certain terms of the credit facility (together with the Fifth Amendment, the “Agreement”), including but not limited to, (i) extending the maturity date from May 7, 2023 to December 31, 2023 (the “2023 Extension Period”), (ii) amending the EBITDA financial covenant of the Company to cover the 2023 Extension Period, and (iii) amending the definition of EBITDA (as defined in the Fifth Amendment). Pursuant to the Fifth Amendment, the Company agreed to pay SVB a non-refundable amendment fee of Thirty Thousand Dollars ($30,000) and SVB’s legal fees and expenses incurred in connection with the Fifth Amendment. In addition, SVB also agreed to waive compliance by the Company of the former EBITDA financial covenant as of the month ended March 31, 2023.

On July 28, 2023, the Company repaid in full all principal outstanding under the SVB Credit Facility, together with all accrued and unpaid interest and related fees, with a portion of the funds from the GBC Credit Facility and terminated the Loan and Security Agreement with SVB, as amended.

During the year ended June 30, 2024, the Company had multiple Revolving LOC drawdowns totaling $1.4 million and multiple Revolving LOC payments totaling $11.3 million inclusive of the final repayment of the LOC in full.

NOTE 9 –RELATED PARTY DEBT AGREEMENTS

At June 30, 2024,2023 and 2022, the Company had no related party debt balance outstanding. Below are the activities for the Company’s related party debt agreements that existed during the years ended June 30, 2024, 2023 and 2022.

Subordinated Line of Credit Facilities

Cleveland Capital, L.P. Credit Facility

On November 2, 2023, the Company entered into a Credit Facility Agreement (the “Credit Facility”) with Cleveland Capital, L.P., (the “Lender”). The Credit Facility provides the Company with a line of credit of up to $2,000,000 for working capital purposes (“2023 Subordinated LOC”). In connection with the LOC, the Company issued a subordinated unsecured promissory note for $2,000,000 (the “Commitment Amount”) in favor of the Lender (the “Note”).

Pursuant to the terms of the Credit Facility, the Lender agreed to make loans (each such loan, an “Advance”) up to such Lender’s Commitment Amount to the Company from time to time, until August 15, 2025 (the “Due Date”). The Note accrues interest at Secured Overnight Financing Rate plus nine percent (9%) per annum on each Advance from and after the date of disbursement of such Advance. All indebtedness, obligations and liabilities of the Company to the Lender are subject to the rights of Gibraltar Business Capital, LLC (together with its successors and assigns, “GBC”), pursuant to a Subordination Agreement dated on or about November 2, 2023, by and between the Lender and GBC (the “Subordination Agreement”). Subject to the Subordination Agreement, the Company may, from time to time, prior to the Due Date, draw down, repay, and re-borrow on the Note, by giving notice to the Lenders of the amount to be requested to be drawn down. Subject to the Subordination Agreement, the Note is payable upon the earlier of (i) the Due Date or (ii) on occurrence of an event of Default (as defined in the Note).

As consideration of the Lender’s commitment to provide the Advances to the Company, the Company issued the Lender warrants to purchase 41,196 shares of common stock (the “Warrants”) which rights are represented by a warrant certificate (“Warrant Certificate”). Subject to certain ownership limitations, the Warrants are exercisable immediately from the date of issuance, expire on the five (5) year anniversary of the date of issuance and have an exercise price of $3.24 per share. The exercise price of the Warrants is subject to certain adjustments, including stock dividends, stock splits, combinations and reclassifications of the common stock. In the event of a Triggering Event (as defined in the Warrant Certificate), the holder of the Warrants will be entitled to exercise the Warrants and receive the same amount and kind of securities, cash or property as such holder would have been entitled to receive upon the occurrence of such Triggering Event if such holder had exercised the rights represented by the Warrant Certificate immediately prior to the Triggering Event. Additionally, upon the holder’s request, the continuing or surviving corporation as a result of such Triggering Event will issue to such holder a new warrant of like tenor evidencing the right to purchase the adjusted amount of securities, cash or property and the adjusted warrant price. (See Note 10 – Stockholders’ Equity).

2022 Subordinated LOC

On May 11, 2022, the Company entered into a Credit Facility Agreement (the “2022 Subordinated LOC”) with Cleveland, Herndon Plant Oakley, Ltd., (“HPO”), and other lenders (together with Cleveland and HPO, the “Lenders”). The 2022 Subordinated LOC provided the Company with a short-term line of credit not less than $3,000,000 and not more than $5,000,000, to be used by the Company for working capital purposes. In connection with the 2022 Subordinated LOC, the Company issued a separate subordinated unsecured promissory note in favor of each respective Lender (each promissory note, a “Note”) for each Lender’s commitment amount (each such commitment amount, a “Commitment Amount”).

Pursuant to the terms of the 2022 Subordinated LOC, each Lender severally agrees to make loans (each such loan, an “Advance”) up to such Lender’s Commitment Amount to the Company from time to time, until December 31, 2022 (the “Due Date”). On December 15, 2022, the Board of Directors of the Company elected to extend the Due Date to December 31, 2023. The Company may, from time to time, prior to the Due Date, draw down, repay, and re-borrow on the Note, by giving notice to the Lenders of the amount to be requested to be drawn down.

Each Note bears an interest rate of 15.0% per annum on each Advance from and after the date of disbursement of such Advance and is payable on (i) the Due Date in cash or shares of common stock of the Company (the “Common Stock”) at the sole election of the Company, unless such Due Date is extended pursuant to the Note, or (ii) on occurrence of an event of Default (as defined in the Note). The Due Date may be extended (i) at the sole election of the Company for one (1) additional year period from the Due Date upon the payment of a commitment fee equal to two percent (2%) of the Commitment Amount to the Lender within thirty (30) days prior to the original Due Date, or (ii) by the Lender in writing. In addition, each Lender signed a Subordination Agreement by and between the Lenders and SVB dated as of May 11, 2022 (the “Subordination Agreement”) for the purposes of subordinating the right to payment under the Note to SVB’s indebtedness by the Company now outstanding or hereinafter incurred. On December 15, 2022, the Board of Directors of the Company elected to extend the Due Date to December 31, 2023 and the Company paid the Lenders an extension fee in the aggregate amount of $80,000. On July 28, 2023, in conjunction with the concurrent termination of the SVB Revolving LOC and the entry into a new credit facility with Gibraltar Business Capital (“GBC”), each Lender signed a Subordination Agreement by and between the Lenders and GBC dated as of July 28, 2023 (the “GBC Subordination Agreement”) for the purposes of subordinating the right to payment under the Note to GBC’s indebtedness by the Company then incurred and outstanding or thereinafter incurred.

The 2022 Subordinated LOC included customary representations, warranties and covenants by the Company and the Lenders. The Company has also agreed to pay the legal fees of Cleveland’s counsel in an amount up to $10,000. In addition, each Note also provides that, upon the occurrence of a Default, at the option of the Lender, the entire outstanding principal balance, all accrued but unpaid interest and/or Late Charges (as defined in the Note) at once will become due and payable upon written notice to the Company by the Lender.

In connection with entry into the 2022 Subordinated LOC, the Company paid to each Lender a one-time commitment fee in cash equal to 3.5% of such Lender’s Commitment Amount. In addition, in consideration of the Lenders’ commitment to provide the Advances to the Company, the Company issued the Lenders five-year warrants to purchase an aggregate of 128,000 shares of common stock at an exercise price of $2.53 per share that are, subject to certain ownership limitations, exercisable immediately (the “Warrants”)(the number of warrants issued to each Lender is equal to the product of (i) 160,000 shares of common stock multiplied by (ii) the ratio represented by each Lender’s Commitment Amount divided by the $5,000,000).

Pursuant to a selling agreement, dated as of May 11, 2022, the Company retained HPO as its placement agent in connection with the Subordinated LOC. As compensation for services rendered in conjunction with the Subordinated LOC, the Company paid HPO a finder fee equal to 3% of the Commitment Amount from each such Lender placed by HPO in cash.

On November 2, 2023, the 2022 Subordinated LOC was terminated.

NOTE 10 –STOCKHOLDERS’ EQUITY

At-The-Market (“ATM”) Offering

On December 21, 2020 the Company entered into a Sales Agreement (the “Sales Agreement”) with H.C. Wainwright & Co., LLC (“HCW”) to sell shares of its common stock, par value $0.001 (the “Common Stock”) from time to time, through an “at-the-market offering” program (the “ATM Offering”).

On October 5, 2023, the Company terminated the Sales Agreement with HCW pursuant to the terms of the Sales Agreement. From December 21, 2020 through October 5, 2023, the Company sold an aggregate of 1,524,873 shares of common stock at an average price of $10.45 per share for gross proceeds of approximately $15.9 million under the ATM Offering. The Company received net proceeds of approximately $15.3 million, net of commissions and other offering related expenses.

Public Offering

Registered Direct Offering

On September 27, 2021, the Company closed a registered direct offering, priced at-the-market under Nasdaq rules (“RDO”) for the sale of 2,142,860 shares of common stock and warrants to purchase up to an aggregate of 1,071,430 shares of common stock, at an offering price of $7.00 per share and associated warrant for gross proceeds of approximately $15.0 million prior to deducting offering expenses totaling approximately $1.0 million. The associated warrants have an exercise price equal to $7.00 per share and are exercisable upon issuance and expire in five years. HCW acted as the exclusive placement agent for the registered direct offering.

The securities sold in the RDO were sold pursuant to a “shelf” registration statement on Form S-3 (File No. 333-249521), including a base prospectus, previously filed with the Securities and Exchange Commission (the “SEC”) on October 16, 2020 and declared effective by the SEC on October 26, 2020. The registered direct offering of the securities was made by means of a prospectus supplement dated September 22, 2021 and filed with the SEC, that forms a part of the effective registration statement. The “shelf” registration statement expired on October 26, 2023.

Warrants

In connection with the Company’s RDO, in September 2021 the Company issued five-year warrants to the RDO investors to purchase up to 1,071,430 shares of the Company’s common stock at an exercise price of $7.00 per share and were estimated to have a fair value of approximately $3,874,000. The warrants were exercisable immediately and are limited to beneficial ownership of 4.99% at any point in time in accordance with the warrant agreement.

In May 2022 and in conjunction with entry into a credit facility with Cleveland, HPO, and other lenders (together with Cleveland and HPO, the “Lenders”), the Company issued five-year warrants to the Lenders to purchase up to 128,000 shares of the Company’s common stock at an exercise price of $2.53 per share and had a fair value of approximately $173,000.

In June 2022 and in conjunction with the entry into the Second Amendment to Loan and Security Agreement with SVB, the Company issued twelve-year warrants to SVB and its designee, SVB Financial Group, to purchase up to 40,806 shares of the Company’s common stock at an exercise price of $2.23 per share and had a fair value of approximately $80,000.

In November 2023 and in conjunction with the entry into the 2023 Subordinated LOC, the Company issued five-year warrants to Cleveland Capital, L.P. to purchase up to 41,196 shares of the Company’s common stock at an exercise price of $3.24 per share with a fair value of approximately $92,000.

Warrant detail for the year ended June 30, 2024 is reflected below:

Number of WarrantsWeighted Average Exercise Price Per WarrantWeighted Average Remaining Contract Term (# years)
Warrants outstanding and exercisable at June 30, 20231,455,119$6.10
Warrants issued41,1963.24
Warrants exercised--
Warrants forfeited and cancelled(83,205)4.00
Warrants outstanding and exercisable at June 30, 20241,413,1106.142.48

Warrant detail for the year ended June 30, 2023 is reflected below:

Number of WarrantsWeighted Average Exercise Price Per WarrantWeighted Average Remaining Contract Term (# years)
Warrants outstanding and exercisable at June 30, 20221,455,119$6.10
Warrants issued--
Warrants outstanding and exercisable at June 30, 20231,455,1196.103.17

Warrant detail for the year ended June 30, 2022 is reflected below:

Number of WarrantsWeighted Average Exercise Price Per WarrantWeighted Average Remaining Contract Term (# years)
Warrants outstanding and exercisable at June 30, 2021214,883$4.49
Warrants issued1,240,2366.38
Warrants outstanding and exercisable at June 30, 20221,455,1196.104.17

The Company uses the Black-Scholes valuation model to calculate the fair value of warrants. The fair value of warrants was measured at the issuance date using the assumptions in the table below:

Year ended June 30,
20242023(1)2022
Expected volatility83.70%-82.45%
Risk free interest rate4.65%-2.89%
Dividend yield-%--%
Expected term (years)5.005.00
(1)No warrants were issued during the year ended June 30, 2023.

Equity Award Plans

In connection with the reverse acquisition of Flux Power, Inc. in 2012, the Company assumed the 2010 Plan. As of June 30, 2024, there weren’t any options to purchase common stock outstanding under the 2010 Plan. No additional options may be granted under the 2010 Plan.

On February 17, 2015, the Company’s stockholders approved the 2014 Equity Incentive Plan (the “2014 Plan”). The 2014 Plan offers certain employees, directors, and consultants the opportunity to acquire the Company’s common stock subject to vesting requirements and serves to encourage such persons to remain employed by the Company and to attract new employees. The 2014 Plan allows for the award of the Company’s common stock and stock options, up to 1,000,000 shares of the Company’s common stock. As of June 30, 2024,89,922 shares of the Company’s common stock were available for future grants under the 2014 Plan.

On April 29, 2021, the Company’s stockholders approved the 2021 Equity Incentive Plan (the “2021 Plan”). The 2021 Plan authorizes the issuance of awards for up to 2,000,000 shares of common stock in the form of incentive stock options, non-statutory stock options, stock appreciation rights, restricted stock units, restricted stock awards and unrestricted stock awards to officers, directors and employees of, and consultants and advisors to, the Company or its affiliates. As of June 30, 2024,777,551 shares of the Company’s common stock were available for future grants under the 2021 Plan.

On October 31, 2022, the Board of Directors authorized a total of 624,441 stock options to be granted under the Company’s 2014 Plan and 2021 Plan.

Stock Options

Activity in stock options during the year ended June 30, 2024 and related balances outstanding as of that date are reflected below:

Number of SharesWeighted Average Exercise PriceWeighted Average Remaining Contract Term (# years)Aggregate intrinsic ValueWeighted Average Grant Date Fair Value
Outstanding at June 30, 2023973,400$6.44
Granted1,034,2043.45$2.24
Exercised(100,104)3.40$97,593
Forfeited and cancelled(302,440)5.66
Outstanding at June 30, 20241,605,0604.857.96–
Exercisable at June 30, 2024426,3638.724.92–

Activity in stock options during the year ended June 30, 2023 and related balances outstanding as of that date are reflected below:

Number of SharesWeighted Average Exercise PriceWeighted Average Remaining Contract Term (# years)Aggregate intrinsic ValueWeighted Average Grant Date Fair Value
Outstanding at June 30, 2022503,433$11.03
Granted624,4413.43$2.88
Exercised(22,500)4.60$2,700
Forfeited and cancelled(131,974)10.03
Outstanding at June 30, 2023973,4006.447.40
Exercisable at June 30, 2023398,92210.774.61

Activity in stock options during the year ended June 30, 2022 and related balances outstanding as of that date are reflected below:

Number of SharesWeighted Average Exercise PriceWeighted Average Remaining Contract Term (# years)Aggregate intrinsic Value
Outstanding at June 30, 2021531,205$11.02
Exercised(3,400)4.65$15,752
Forfeited and cancelled(24,372)11.65
Outstanding and exercisable at June 30, 2022503,43311.035.66

The Company uses the Black-Scholes valuation model to calculate the fair value of stock options. The fair value of stock options was measured at the grant date using the assumptions (annualized percentages) in the table below:

Year ended June 30,
202420232022(1)
Expected volatility80.06%90.12%-
Risk free interest rate4.864.21-
Forfeiture rate20.0020.00-
Dividend yield––-
Expected term (years)6.006.25
(1)No stock options were granted during the year ended June 30, 2022.

Restricted Stock Units

On November 5, 2020, the Company’s Board of Directors approved an amendment to the 2014 Plan, to allow for grants of Restricted Stock Units (“RSUs”). Subject to vesting requirements set forth in the RSU Award Agreement, one share of common stock is issuable for one vested RSU. On April 29, 2021, a total of 18,312 time-based RSUs were authorized by the Company’s Board of Directors to be granted under the amended 2014 Option Plan. On October 29, 2021, the Board of Directors authorized the following RSUs to be granted under the amended 2014 Option Plan: (i) a total of 97,828 RSUs to certain executive officers of which 48,914 were performance-based RSUs and 48,914 were time-based RSUs, and (ii) a total of 81,786 time-based RSUs to certain other key employees. The RSUs are subject to the terms and conditions provided in (i) the Restricted Stock Unit Award Agreement for time-based awards (“Time-based Award Agreement”), and (ii) the Performance Restricted Stock Unit Award Agreement for performance-based awards (“Performance-based Award Agreement”). Under the amended 2014 Option Plan and 2021 Plan, a total of 68,228 and 57,532 of time-based RSUs were authorized on April 18, 2024 and April 20, 2023, respectively, by the Company’s Board of Directors to be granted to the Company’s four non-executive directors.

Activity in RSUs during the year ended June 30, 2024 and related balances outstanding as of that date are reflected below:

Number of SharesWeighted Average Exercise PriceWeighted Average Remaining Contract Term (# years)
Outstanding at June 30, 2023193,749$6.09
Granted68,2284.25
Vested and settled(136,956)5.55
Forfeited and cancelled(10,355)6.91
Outstanding at June 30, 2024114,6665.560.61

Activity in RSUs during the year ended June 30, 2023 and related balances outstanding as of that date are reflected below:

Number of SharesWeighted Average Exercise PriceWeighted Average Remaining Contract Term (# years)
Outstanding at June 30, 2022304,221$6.06
Granted72,5663.44
Vested and settled(109,676)3.77
Forfeited and cancelled(73,362)6.80
Outstanding at June 30, 2023193,7496.090.98

Activity in RSUs during the year ended June 30, 2022 and related balances outstanding as of that date are reflected below:

Number of SharesWeighted Average Exercise PriceWeighted Average Remaining Contract Term (# years)
Outstanding at June 30, 2021131,652$9.25
Granted250,7864.82
Vested and settled(9,156)11.56
Forfeited and cancelled(69,061)6.93
Outstanding at June 30, 2022304,2216.061.82

Employee Stock Purchase Plan

On March 6, 2023, the Company’s Board of Directors approved the 2023 Employee Stock Purchase Plan (the “2023 ESPP”), which subsequently was approved by the Company’s stockholders on April 20, 2023. The 2023 ESPP enables eligible employees of the Company and certain of its subsidiaries (a “Participating Subsidiary”) to use payroll deductions to purchase shares of the Company’s Common Stock and acquire an ownership interest in the Company. The maximum aggregate number of shares of the Company’s Common Stock that have been reserved as authorized for the grant of options under the 2023 ESPP is 350,000 shares, subject to adjustment as provided for in the 2023 ESPP. Participation in the 2023 ESPP is voluntary and is limited to eligible employees (as such term is defined in the 2023 ESPP) of the Company or a Participating Subsidiary who(i) has been employed by the Company or a Participating Subsidiary for at least 90 days and (ii) is customarily employed for at least twenty (20) hours per week and more than five (5) months in any calendar year. Each eligible employee may authorize payroll deductions of 1-15% of the eligible employee’s compensation on each pay day to be used to purchase up to 1,500 shares of Common Stock for the employee’s account occurring during an offering period. The 2023 ESPP has a term of ten (10) years commencing on April 20, 2023, the date of approval by the Company’s stockholders, unless otherwise earlier terminated.

On March 28, 2024, participants in the 2023 ESPP purchased an aggregate total of 37,543 shares of common stock at a price equal to 85% of $3.30, which was the closing price of the Company’s common stock on the offering date pursuant to the provisions of the 2023 ESPP.

At June 30, 2024,312,457 shares of the Company’s common stock were available for future grants under the 2023 ESPP.

Stock-based Compensation

Stock-based compensation expense for the fiscal years ended June 30, 2024 and 2023 represents the estimated fair value of stock options, RSUs and ESPP offerings at the time of grant amortized under the straight-line method over the expected vesting period and reduced for estimated forfeitures of options and RSUs. Forfeitures are estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from original estimates. At June 30, 2024, the aggregate intrinsic value of the outstanding options and the exercisable options were zero andzero, respectively.

The following table summarizes stock-based compensation expense for employee and non-employee option and RSU grants:

Year ended June 30,
202420232022
Research and development$1,335,000$173,000$144,000
Selling and administrative236,000625,000567,000
Total stock-based compensation expense$1,571,000$798,000$711,000

At June 30, 2024, the unamortized stock-based compensation expense relating to outstanding stock options and RSUs was approximately $2,282,000 and $319,000, respectively, and these amounts are expected to be expensed over the weighted-average remaining recognition period of 1.60 years and 0.44 years, respectively.

NOTE 11 –INCOME TAXES

Pursuant to the provisions of FASB ASC Topic No. 740Income Taxes (“ASC 740”), deferred income taxes reflect the net effect of (a) temporary difference between carrying amounts of assets and liabilities for financial purposes and the amounts used for income tax reporting purposes, and (b) net operating loss and tax credit carryforwards. A valuation allowance of approximately $26,483,000, $24,696,000 and $23,461,000 has been established to offset the net deferred tax assets as of June 30, 2024, 2023 and 2022, respectively, due to uncertainties surrounding the Company’s ability to generate future taxable income to realize these assets.

The Company is subject to taxation in the United States, California and Georgia. The Company’s tax years from 2010 and forward are subject to examination by the United States and state taxing authorities due to the carry forward of unutilized net operating losses and research and development credits, as applicable.

The Company has incurred losses since inception. A current state income tax provision of $3,000 has been recorded for state minimum and net worth taxes. Significant components of the Company’s net deferred tax assets and liabilities are shown in the table below.

Year ended June 30,
202420232022
Restated · Restated
Deferred tax assets:
Net operating loss carryforwards$21,553,000$20,941,000$20,780,000
Research and development credit carryforward27,00027,00027,000
Capitalized research and development expenses1,987,0001,320,000–
Stock compensation638,000971,0001,636,000
Disallowed interest expense431,000––
Lease liability567,000736,000802,000
Other, net1,785,0001,366,000943,000
Gross deferred tax assets26,988,00025,361,00024,188,000
Less valuation allowance(26,483,000)(24,696,000)(23,461,000)
Total deferred tax assets505,000665,000727,000
Deferred tax liabilities:
Right of use asset(505,000)(665,000)(727,000)
Total deferred tax liabilities(505,000)(665,000)(727,000)
Total net deferred tax liabilities$–$–$–

At June 30, 2024, the Company had unused net operating loss (“NOL”) carryovers of approximately $74,816,000 and $84,522,000 that are available to offset future federal and state taxable income, respectively. Federal NOL carryforwards arising after 2017 of approximately $42,408,000 do not expire. Federal NOL carryforwards arising before 2018 of approximately $22,408,000 and all of the state NOL carryforward begin to expire in 2030.

The provision for income taxes on earnings subject to income taxes differs from the statutory federal rate at June 30, 2024 and 2023, due to the following:

Year ended June 30,
2024 · 2023 · 2022
Restated · Restated
Federal income taxes at 21%$(1,749,000)$(1,625,000)$(3,459,000)
State income taxes, net(546,000)(485,000)(1,151,000)
Permanent differences and other241,000152,000102,000
Other true ups270,000725,000(113,000)
Change in valuation allowance1,787,0001,235,0004,621,000
Provision for income taxes$3,000$2,000$-

Internal Revenue Code Sections 382 limits the use of our net operating loss carryforwards if there has been a cumulative change in ownership of more than 50% within a three-year period. The Company has not yet completed a Section 382 net operating loss analysis. If such analysis determines there is a limitation on the use on net operating loss carryforwards to offset future taxable income, the recorded deferred tax asset relating to such net operating loss carryforwards will be reduced. However, as the Company has recorded a full valuation allowance against its net deferred tax assets, there would be no impact on the Company’s consolidated financial statements as of June 30, 2024, 2023 and 2022.

Under ASC 740, the impact of an uncertain income tax position on the income tax return must be recognized at the largest amount that is more-likely-than-not to be sustained upon audit by the relevant taxing authority. An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being sustained. Additionally, ASC 740 provides guidance on de-recognition, classification, interest and penalties, accounting in interim periods, disclosure and transition.

In accordance with ASC 740, there areno unrecognized tax benefits as of June 30, 2024, 2023 or 2022.

NOTE 12 –CONCENTRATIONS

Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and unsecured trade accounts receivable. The Company maintains cash balances in non-interest-bearing bank deposit accounts at a California commercial bank. The Company’s cash balance at this institution is secured by the Federal Deposit Insurance Corporation up to $250,000. As of June 30, 2024, 2023 and 2022, cash was approximately $643,000, $2.4 million and $485,000, respectively.

On March 10, 2023, the Federal Deposit Insurance Corporation (the “FDIC”) issued a press release stating that Silicon Valley Bank (“SVB”) was closed by the California Department of Financial Protection and Innovation, which appointed the FDIC as receiver. In a joint statement issued by the Department of the Treasury, Board of Governors of the Federal Reserve System and Federal Deposit Insurance Corporation on March 12, 2023, the Department of Treasury took actions to enable the FDIC to complete its resolution of SVB in a manner that fully protects all depositors. According to the joint statement (the “Statement”), depositors will have access to all of their money starting Monday, March 13, 2023. On March 13, 2023, Silicon Valley Bridge Bank, N.A., the new entity formed by the FDIC announced appointment of a new CEO, who provided assurance of immediate restoration of full banking services. On March 27, 2023, First Citizens BancShares, Inc. announced that it has entered into an agreement with the FDIC to purchase all of the assets and liabilities of Silicon Valley Bridge Bank, N.A.

The Company has not experienced any losses in such accounts. Management believes that the Company is not exposed to any significant credit risk with respect to its cash.

Customer Concentrations

During the year ended June 30, 2024, the Company had three (3) major customers that each represented more than 10% of its revenues on an individual basis, and together represented approximately $47,178,000 or 78% of its total revenues.

During the year ended June 30, 2023, the Company had three (3) major customers (as restated) that each represented more than 10% of its revenues on an individual basis, and together represented approximately $53,140,000 (as restated) or 80% (as restated) of its total revenues.

During the year ended June 30, 2022, the Company had four (4) major customers that each represented more than 10% of its revenues on an individual basis, and together represented approximately $35,229,000 (as restated) or 83% (as restated) of its total revenues.

Suppliers/Vendor Concentrations

The Company obtains a limited number of components and supplies included in its products from a small group of suppliers. During the year ended June 30, 2024 the Company had one (1) supplier who accounted for more than 10% of its total purchases which represented approximately $12,437,000 or 27% of its total purchases.

During the year ended June 30, 2023 the Company had one (1) supplier who accounted for more than 10% of its total purchases which represented approximately $17,022,000 or 31% of its total purchases.

During the year ended June 30, 2022 the Company had one (1) supplier who accounted for more than 10% of its total purchases which represented approximately $13,884,000 or 28% of its total purchases

NOTE 13 –COMMITMENTS AND CONTINGENCIES

From time to time, the Company may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. However, litigation is subject to inherent uncertainties and an adverse result in any legal proceedings that may arise from time to time may harm the Company’s business. To the best of its knowledge, except for the legal proceedings disclosed below, there are no other material legal proceedings pending against the Company.

Securities Class Action

On November 1, 2024, plaintiff Asfa Kassam filed a purported federal securities class action complaint in the United States District Court, District of Nevada, captionedKassam v. Flux Power Holdings, Inc. et al. (No. 2:24-cv-02051), against the Company, our Chief Executive Officer, Ronald F. Dutt, and our former Chief Financial Officer, Charles A. Scheiwe. The complaint generally alleges that the defendants made false and misleading statements in violation of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, and Rule 10b-5 promulgated thereunder. The action purports to be brought on behalf of those who purchased or otherwise acquired the Company’s publicly traded securities between November 11, 2022 and September 30, 2024, and seeks unspecified damages and other relief. On January 14, 2025, the court granted an unopposed motion to transfer the case to the Southern District of California for all further proceedings. The case is in its early stages and a lead plaintiff has yet to be appointed. Management believes these claims to be meritless and intends to vigorously defend against them.

Shareholder Derivative Action

On January 7, 2025, plaintiff Ronald Pearl filed a purported shareholder derivative complaint in the United States District Court, District of Nevada, captionedPearl v. Dutt, et al. (No. 2:25-cv-00042), against current and former officers and directors of the Company, naming the Company as a nominal defendant. The complaint generally arises out of the same allegations contained in theKassam securities class action and alleges claims for breach of fiduciary duties and related claims. The action purports to be brought derivatively on behalf of the Company and seeks damages and other various relief.

Employment Related Actions

On April 30, 2024, a former employee (the “Employee”) filed a class action complaint against the Company and Insperity, its third-party payroll service provider, in San Diego County Superior Court for claims including failure to pay minimum wage, failure to pay overtime, failure to provide meal periods, failure to provide rest breaks, failure to pay wages at separation, failure to provide accurate wage statements, failure to reimburse business expenses, failure to produce employment records and unfair competition, which he has purported to assert on behalf of himself and all other individuals who worked for the Company or Insperity, as non-exempt employees in California between April 30, 2020 and the present (the “Employment Proceeding”). On July 1, 2024, the Company filed an answer to the complaint that none of the asserted claims possessed any merit, contended that many of the asserted claims were subject to immediate dismissal, and contended that certain of the asserted claims were subject to binding arbitration. On October 14, 2024, the Employee elected to dismiss Insperity from the action without prejudice.

On July 5, 2024, the Employee filed a representative action complaint against the Company and Insperity in San Diego County Superior Court for Violation of Private Attorneys’ General Act (“PAGA”), seeking an unspecified amount of penalties and attorneys’ fees based on allegations that the Compnay violated certain California employment laws (the “PAGA Proceeding”). On August 8, 2024, the Company filed an answer to the complaint in which the Company denied that any of the asserted claims possessed any merit and contended that certain of the asserted claims were subject to binding arbitration.

On December 10, 2024, the Company and the Employee stipulated to the consolidation of Employment Lawsuit and the PAGA Action. As of the date hereof, both proceedings are currently pending consolidation by the court. Upon consolidation, the Company intends to move to have the Employee’s action claims dismissed, the Employee’s individual claims compelled to binding arbitration and the Employee’s representative PAGA claims stayed pending the arbitration of his individual claims. On October 22, 2024, the Employee elected to dismiss Insperity from the action without prejudice.

On January 25, 2024, a former CPM, LTD Inc. (“CPM”) employee filed a complaint against CPM, a third-party staffing service provider, Flux Power, Inc., and Flux Power Holdings, Inc. (collectively, the “Defendants”) in San Diego County Superior Court for claims including harassment, failure to prevent harassment, retaliation, wrongful termination, failure to provide meal periods and rest breaks, failure to provide accurate wage statements, and failure to pay wages at separation. CPM is a San Diego based staffing company that provided employees (including the plaintiff) to the Company. The plaintiff has alleged that the Company and CPM were “joint employers” to the plaintiff under California law and are jointly liable for the plaintiff’s claims. The plaintiff is seeking an unspecified amount of unpaid wages, statutory penalties, emotional distress damages, punitive damages, and attorneys’ fees from Defendants. On June 21, 2024, the Company filed an answer to the complaint in which the Company denied that any of the asserted claims possessed any merit and contended that certain of the asserted claims were subject to binding arbitration.

It is not possible at this time to reasonably assess the final outcomes of these proceedings or reasonably to estimate the possible loss or range of loss with respect to these proceedings. The Company intends to vigorously defend against these claims.

Operating Leases

On April 25, 2019 the Company signed a Standard Industrial/Commercial Multi-Tenant Lease (“Lease”) with Accutek to rent approximately 45,600 square feet of industrial space at 2685 S. Melrose Drive, Vista, California. The Lease has an initial term of seven years and four months and commenced on or about June 28, 2019. The lease contains an option to extend the term for two periods of 24 months each, and the right of first refusal to lease an additional approximate 15,300 square feet. The monthly rental rate was $42,400 for the first 12 months, escalating at 3% each year.

On February 26, 2020, the Company entered into the First Amendment to Standard Industrial/Commercial Multi-Tenant Lease dated April 25, 2019 (the “Amendment”) with Accutek to rent an additional 16,309 rentable square feet of space plus a residential unit of approximately 1,230 rentable square feet (for a total of approximately 17,539 rentable square feet). The lease for the additional space commenced 30 days following the occupancy date of the additional space and will terminate concurrently with the term of the original lease, which expires on November 20, 2026. The base rent for the additional space is the same rate as the space rented under the terms of the original lease, $0.93 per rentable square foot (subject to 3% annual increase). In connection with the Amendment, the Company purchased certain existing office furniture for a total purchase price of $8,300.

On December 16, 2022 the Company signed a Lease Agreement with MM Parker Court Associates, LLC to rent approximately 4,892 square feet of office space at Building 1959 Parker Court, Suite E, Atlanta, Georgia. The Lease has an initial term of five years and three months and commenced on or about February 1, 2023. The monthly rental rate was approximately $2,300 for the first 6 months, and $4,700 for months 7 to 12, escalating at 5% each year.

Total rent expense was approximately $942,000, $899,000 and $867,000 for the fiscal years ended June 30, 2024, 2023 and 2022, respectively.

Finance Leases

The Company has finance leases outstanding as of June 30, 2024 as follows:

Lease DateProperty LeasedLease Term (months)Commencement DateMonthly Lease Payment(1)
9/2/2022Vehicle609/10/2022$1,100
10/17/2022Manufacturing equipment3610/17/2022$5,500
1/24/2023Manufacturing equipment361/24/2023$6,700
3/2/2023Manufacturing equipment363/2/2023$1,000
(1)Excludes sales tax and other fees.

Lease costs are amortized on a straight-line basis over their respective lease terms. Depreciation expense related to leased assets was approximately $153,000 and $86,000 for the years ended June 30, 2024 and 2023, respectively. Interest expense on leased liabilities was approximately $29,000 and $23,000 for the years ended June 30, 2024 and 2023, respectively. The Company did not have any finance leases during the year ended June 30, 2022.

Future minimum lease payments as of June 30, 2024 are as follows:

Operating Leases · Finance Leases
Years ending June 30,
2025$882,000$172,000
2026910,00085,000
2027433,00015,000
202864,00021,000
2029--
Total future minimum lease payments2,289,000293,000
Less: discount(234,000)(25,000)
Total lease liability2,055,000268,000
Less: leases payable, current portion(734,000)(156,000)
Leases payable, noncurrent portion$1,321,000$112,000

The weighted average remaining lease term for operating leases was 2.6 years,3.6 years and 4.4 years as of June 30, 2024, 2023 and 2022, respectively. The weighted average discount rate for operating leases was 8.8%,8.9% and 10.0% as of June 30, 2024, 2023 and 2022, respectively.

The weighted average remaining lease term for finance leases was 1.6 years and 2.6 years as of June 30, 2024 and 2023, respectively. The weighted average discount rate for finance leases was 1.9% and 1.7% as of June 30, 2024 and 2023, respectively. There wereno finance leases as of June 30, 2022.

NOTE 14 –SUBSEQUENT EVENTS

On November 20, 2024, Ronald F. Dutt, the Company’s chairman and Chief Executive Officer, notified the Company’s Board of Directors of his intentions to retire from his positions upon the appointment of a new Chief Executive Officer. The Board has commenced a search for a new Chief Executive Officer and Mr. Dutt will remain with the Company through the search and transition period.

Waivers to Loan and Security Agreement with Gibraltar Business Capital

As previously announced in the Company’s Form 8-K filed with the SEC on September 5, 2024, the Board of Directors of the Company, including its audit committee members, concluded on August 30, 2024 that the previously issued audited consolidated financial statements for the fiscal years ended June 30, 2023 and 2022, and all of the quarterly unaudited consolidated financial statements within the fiscal years ended June 30, 2024, 2023 and 2022 (collectively, the “Prior Financial Statements”), could no longer be relied upon due to material accounting errors identified by management. See Note 15 – Restatement of Previously Issued Financial Statements.

The Company notified GBC that the restatement of historical financial statements was likely to result in event of default with respect to the Company’s failure to maintain the EDITDA covenant for the trailing three (3) month periods ended July 31, 2023 and August 31, 2023, or Default. On August 30, 2025, the Company received a Waiver, which waived the Default, subject to satisfaction of the following conditions: (i) receipt of a counterpart of the Waiver duly executed by the Company; and (ii) receipt of the representations and warranties from the Company that after giving effect to the Waiver, the representations and warranties contained in the Agreement, the Waiver and the other Loan Documents shall be true and correct; and (iii) after giving effect to the Waiver, no additional event of default shall have occurred and be continuing on and as of the effective date of the Waiver.

The Company’s failure to file this Annual Report on Form 10-K for the year ended June 30, 2024 in a timely manner resulted in an event of default with respect to the covenant to timely deliver a copy of the Company’s annual audited financial statements. Additionally, the Company notified GBC that it appeared likely that as a result of the restatement it would fail to maintain the EBITDA covenant for the trailing three (3) month periods ended May 31, 2024 and July 31, 2024, or Default. On January 17, 2025, the Company received a Waiver, which waived the Defaults, subject to satisfaction of the following conditions: (i) receipt of a counterpart of the Waiver duly executed by the Company; and (ii) receipt of the waiver fee of $25,000; and (iii) receipt of the representations and warranties from the Company that after giving effect to the Waiver, the representations and warranties contained in the Agreement, the Waiver and the other Loan Documents shall be true and correct; and (iv) after giving effect to the Waiver, no additional event of default shall have occurred and be continuing on and as of the effective date of the Waiver.

Amendment to Loan and Security Agreement with Gibraltar Business Capital

On January 22, 2025, we entered into Amendment No. 4 to Loan and Security Agreement (the “Fourth Amendment”) with GBC which amended certain terms of the Loan and Security Agreement dated July 28, 2023, as amended, relating to the EBITDA Minimum financial covenant of the Company. In consideration for the Fourth Amendment, the Company agreed to pay GBC a non-refundable amendment fee of $50,000 in cash, as follows: (i) $25,000 shall be due and payable on March 1, 2025, and (ii) $25,000 shall be due and payable on April 1, 2025.

NOTE 15 –RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS

As described in Note 2 – Restatement of Previously Issued Financial Statements, and as further described below, in connection with the preparation of its consolidated financial statements as of and for the year ended June 30, 2024, the Company identified multiple prior-period misstatements that were improperly accounted for in its previously issued audited consolidated financial statements for the fiscal years ended June 30, 2023 and 2022.

The nature of the restatement adjustments and their impact on previously reported consolidated financial statements are as follows:

(a) Inventories. The Company did not properly evaluate its calculation of its excess and obsolescence reserve on its finished goods and raw materials inventories, resulting in an overstatement of inventories of $926,000 and $764,000 as of June 30, 2023 and 2022, respectively, an understatement of accumulated deficit of $521,000 as of June 30, 2021, and an understatement of cost of sales of $162,000 and $243,000 for the years ended June 30, 2023, and 2022, respectively. In addition, certain inventory components were not properly recorded at the lower of cost or net realizable value, resulting in an overstatement of inventories of $781,000 and $607,000 as of June 30, 2023 and 2022, respectively, an understatement of accumulated deficit of $296,000 as of June 30, 2021, and an understatement of cost of sales of $174,000 and $311,000 for the years ended June 30, 2023 and 2022, respectively. Further, certain loaner service packs and consigned inventory were not reconciled in a timely manner, resulting in an overstatement of inventories of $670,000 and $210,000 as of June 30, 2023 and 2022, respectively, and an understatement of cost of sales of $460,000 and $210,000 for the years ended June 30, 2023 and 2022, respectively. Additionally, the Company did not properly present inventory write downs on the consolidated statement of cash flows resulting in an understatement of inventory write downs of $354,000 and $111,000 and corresponding overstatement of changes in inventories of $354,000 and $111,000 on the consolidated statement of cash flows for the years ended June 30, 2023 and 2022, respectively.

(b) Revenues. The Company did not properly recognize revenue in the periods in which the related performance obligations were satisfied for a certain contract with a customer, resulting in an understatement of revenues of $151,000 for the year ended June 30, 2023 and a corresponding understatement of accounts receivable of $151,000 as of June 30, 2023.

(c) Expense classification. The Company improperly recorded various inventory write downs to research and development expenses although such expenses did not meet the classification criteria for research and development under ASC 730, resulting in an overstatement of research and development expenses and a corresponding understatement of cost of sales of $208,000 and $828,000 for the years ended June 30, 2023 and 2022, respectively.

(d) Other. The Company had various clearing accounts that were not reconciled in a timely manner, resulting in an understatement of accounts payable of $137,000 as of June 30, 2023, overstatement of inventories of $461,000 and $241,000 as of June 30, 2023 and 2022, respectively, an understatement of accumulated deficit of $141,000 as of June 30, 2021, and understatement of cost of sales of $357,000 and $100,000 for the years ended June 30, 2023 and 2022, respectively.

(e) Cash flow presentation of debt issuance cost in the form of issued Company stock warrants. The Company erroneously presented $253,000 of debt issuance cost incurred in conjunction with credit facility arrangements made during the year ended June 30, 2022 as fair value of warrants issued, an adjustment to reconcile net loss to cash used in operating activities in the Company’s consolidated statement of cash flows for the year ended June 30, 2022. As debt issuance costs are recorded as a current asset, the presentation overstated items reconciling net loss to cash used in operating activities and understated the change in other assets in the consolidated statement of cash flows. Additionally, the Company improperly omitted the non-cash disclosure related to the issuance of warrants within the supplemental disclosures of non-cash investing and financing activities for the year ended June 30, 2022.

Below are the restated consolidated balance sheets as of June 30, 2023 and 2022, and the restated consolidated statements of operations, statements of stockholders’ equity and statements of cash flows for each of the years ended June 30, 2023 and 2022 that summarize the effects of the restatement.

As previously reportedRestatement adjustmentsReferenceAs restated
ASSETS
Current assets:
Cash$2,379,000$–$2,379,000
Accounts receivable (b)8,649,000151,000(b)8,800,000
Inventories, net (a)(d)18,996,000(2,838,000)(a) (d)16,158,000
Other current assets918,000-918,000
Total current assets30,942,000(2,687,000)28,255,000
Right of use asset2,854,000–2,854,000
Property, plant and equipment, net1,789,000–1,789,000
Other assets120,000–120,000
Total assets$35,705,000$(2,687,000)$33,018,000
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable (b)(d)$9,735,000$137,000(d)$9,872,000
Accrued expenses3,181,000–3,181,000
Line of credit9,912,000–9,912,000
Deferred revenue131,000–131,000
Customer deposits82,000–82,000
Finance leases payable, current portion143,000–143,000
Office leases payable, current portion644,000–644,000
Accrued interest2,000–2,000
Total current liabilities23,830,000137,00023,967,000
Long term liabilities:
Finance leases payable, less current portion273,000–273,000
Office leases payable, less current portion2,055,000–2,055,000
Total liabilities26,158,000137,00026,295,000
Stockholders’ equity:
Preferred stock, $0.001 par value; 500,000 shares authorized; none issued and outstanding---
Common stock, $0.001 par value; 30,000,000 shares authorized; 16,462,215 shares issued and outstanding16,000–16,000
Additional paid-in capital98,086,000–98,086,000
Accumulated deficit (a)(b)(d)(88,555,000)(2,824,000)(a) (b) (d)(91,379,000)
Total stockholders’ equity9,547,000(2,824,000)6,723,000
Total liabilities and stockholders’ equity$35,705,000$(2,687,000)$33,018,000
As previously reportedRestatement adjustmentsReferenceAs restated
ASSETS
Current assets:
Cash$485,000$–$485,000
Accounts receivable8,609,000–8,609,000
Inventories, net (a)(d)16,262,000(1,822,000)(a) (d)14,440,000
Other current assets1,261,000–1,261,000
Total current assets26,617,000(1,822,000)24,795,000
Right of use asset2,597,000–2,597,000
Property, plant and equipment, net1,578,000–1,578,000
Other assets89,000–89,000
Total assets$30,881,000$(1,822,000)$29,059,000
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable$6,645,000$–$6,645,000
Accrued expenses2,209,000–2,209,000
Line of credit4,889,000–4,889,000
Deferred revenue163,000–163,000
Customer deposits175,000–175,000
Office leases payable, current portion504,000–504,000
Accrued interest1,000–1,000
Total current liabilities14,586,000–14,586,000
Long term liabilities:
Office leases payable, less current portion2,361,000–2,361,000
Total liabilities16,947,000–16,947,000
Stockholders’ equity:
Preferred stock, $0.001 par value; 500,000 shares authorized; none issued and outstanding---
Common stock, $0.001 par value; 30,000,000 shares authorized; 15,996,658 shares issued and outstanding16,000–16,000
Additional paid-in capital95,732,00095,732,000
Accumulated deficit (a)(d)(81,814,000)(1,822,000)(a) (d)(83,636,000)
Total stockholders’ equity13,934,000(1,822,000)12,112,000
Total liabilities and stockholders’ equity$30,881,000$(1,822,000)$29,059,000
As previously reportedRestatement adjustmentsReferenceAs restated
Revenues (b)$66,337,000$151,000(b)$66,488,000
Cost of sales (a)(c)(d)49,237,0001,361,000(a) (c) (d)50,598,000
Gross profit17,100,000(1,210,000)15,890,000
Operating expenses:
Selling and administrative17,620,000–17,620,000
Research and development (c)4,890,000(208,000)(c)4,682,000
Total operating expenses22,510,000(208,000)22,302,000
Operating loss(5,410,000)(1,002,000)(6,412,000)
Other income (expense):
Other income8,000–8,000
Interest income (expense), net(1,339,000)–(1,339,000)
Net loss$(6,741,000)$(1,002,000)$(7,743,000)
Net loss per share - basic and diluted$(0.42)$(0.06)$(0.48)
Weighted average number of common shares outstanding - basic and diluted16,055,25616,055,25616,055,256
As previously reportedRestatement adjustmentsReferenceAs restated
Revenues$42,333,000$–$42,333,000
Cost of sales (a)(c)(d)35,034,0001,692,000(a) (c) (d)36,726,000
Gross profit7,299,000(1,692,000)5,607,000
Operating expenses:
Selling and administrative15,515,000–15,515,000
Research and development (c)7,141,000(828,000)(c)6,313,000
Total operating expenses22,656,000(828,000)21,828,000
Operating loss(15,357,000)(864,000)(16,221,000)
Other income (expense):
Interest income (expense), net(252,000)–(252,000)
Net loss$(15,609,000)$(864,000)$(16,473,000)
Net loss per share - basic and diluted$(1.01)$(0.06)$(1.07)
Weighted average number of common shares outstanding - basic and diluted15,439,53015,439,53015,439,530

CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY

Common Stock
ReferenceSharesCapital Stock AmountAdditional Paid-in CapitalAccumulated DeficitTotal
As previously reported
Balance, June 30, 202215,996,658$16,000$95,732,000$(81,814,000)$13,934,000
Issuance of common stock – public offering, net of costs355,309–1,556,000–1,556,000
Issuance of common stock – exercised options and RSU settlement110,248––––
Stock-based compensation––798,000–798,000
Net loss–––(6,741,000)(6,741,000)
Balance, June 30, 202316,462,21516,00098,086,000(88,555,000)9,547,000
Adjustments
Balance, June 30, 2022 (a)(d)(a) (d)–––(1,822,000)(1,822,000)
Net loss (a) (b) (d)(a) (b) (d)–––(1,002,000)(1,002,000)
Balance, June 30, 2023–––(2,824,000)(2,824,000)
As restated
Balance, June 30, 202215,996,65816,00095,732,000(83,636,000)12,112,000
Issuance of common stock – public offering, net of costs355,309–1,556,000–1,556,000
Issuance of common stock – exercised options and RSU settlement110,248––––
Stock-based compensation––798,000–798,000
Net loss–––(7,743,000)(7,743,000)
Balance, June 30, 202316,462,215$16,000$98,086,000$(91,379,000)$6,723,000

CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY

Common Stock
ReferenceSharesCapital Stock AmountAdditional Paid-in CapitalAccumulated DeficitTotal
As previously reported
Balance, June 30, 202113,652,164$14,000$79,197,000$(66,205,000)$13,006,000
Issuance of common stock and warrants - registered direct offering, net of costs2,142,8602,00013,969,000–13,971,000
Issuance of common stock – public offering, net of costs190,782–1,602,000–1,602,000
Issuance of common stock - exercised options and RSU settlement10,852––––
Fair value of warrants issued––253,000–253,000
Stock-based compensation––711,000–711,000
Net loss–––(15,609,000)(15,609,000)
Balance, June 30, 202215,996,65816,00095,732,000(81,814,000)13,934,000
Adjustments
Balance, June 30, 2021 (a)(d)(a) (d)–––(958,000)(958,000)
Net loss (a)(d)(a) (d)–––(864,000)(864,000)
Balance, June 30, 2022–––(1,822,000)(1,822,000)
As restated
Balance, June 30, 202113,652,16414,00079,197,000(67,163,000)12,048,000
Issuance of common stock and warrants - registered direct offering, net of costs2,142,8602,00013,969,000–13,971,000
Issuance of common stock – public offering, net of costs190,782–1,602,000–1,602,000
Issuance of common stock - exercised options and RSU settlement10,852––––
Fair value of warrants issued––253,000–253,000
Stock-based compensation––711,000–711,000
Net loss–––(16,473,000)(16,473,000)
Balance, June 30, 202215,996,658$16,000$95,732,000$(83,636,000)$12,112,000
As previously reportedRestatement adjustmentsReferenceAs restated
Cash flows from operating activities:
Net loss (a)(b)(d)$(6,741,000)$(1,002,000)(a) (b) (d)$(7,743,000)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation899,000–899,000
Stock-based compensation798,000–798,000
Amortization of debt issuance costs482,000–482,000
Non-cash lease expense512,000–512,000
Inventory write downs (a)–690,000(a)690,000
Changes in operating assets and liabilities:
Accounts receivable (b)(40,000)(151,000)(b)(191,000)
Inventories (a)(d)(2,734,000)326,000(a) (d)(2,408,000)
Other assets(170,000)–(170,000)
Accounts payable (b)(d)3,090,000137,000(d)3,227,000
Accrued expenses972,000–972,000
Accrued interest(32,000)–(32,000)
Office leases payable1,000–1,000
Deferred revenue(518,000)–(518,000)
Customer deposits(93,000)–(93,000)
Net cash used in operating activities(3,574,000)–(3,574,000)
Cash flows from investing activities:
Purchases of equipment(1,032,000)–(1,032,000)
Proceeds from sale of fixed assets8,000–8,000
Net cash used in investing activities(1,024,000)–(1,024,000)
Cash flows from financing activities:
Proceeds from the issuance of common stock in public offering, net of offering costs1,556,000–1,556,000
Proceeds from revolving line of credit63,400,000–63,400,000
Payment of revolving line of credit(58,377,000)–(58,377,000)
Payment of finance leases(87,000)–(87,000)
Net cash provided by financing activities6,492,000–6,492,000
Net change in cash1,894,000–1,894,000
Cash, beginning of period485,000–485,000
Cash, end of period$2,379,000$–$2,379,000
Supplemental Disclosures of Non-Cash Investing and Financing Activities:
Initial right of use asset recognition$855,000$–$855,000
Common stock issued for vested RSUs$417,000$–$417,000
Supplemental cash flow information:
Interest paid$1,127,000$–$1,127,000
As previously reported · Restatement adjustments · Reference · As restated
Cash flows from operating activities:
Net loss (a)(d)$(15,609,000)$(864,000)(a) (d)$(16,473,000)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation575,000–575,000
Stock-based compensation711,000–711,000
Fair value of warrants issued as debt discount cost253,000(253,000)(e)–
Non-cash lease expense438,000–438,000
Inventory write downs (a)61,000604,000(a)665,000
Changes in operating assets and liabilities: (a)
Accounts receivable(2,512,000)–(2,512,000)
Inventories (a)(d)(5,810,000)260,000(a) (d)(5,550,000)
Other assets(802,000)253,000(e)(549,000)
Accounts payable(530,000)–(530,000)
Accrued expenses(374,000)–(374,000)
Accrued interest139,000–139,000
Office leases payable(1,000)–(1,000)
Deferred revenue(436,000)–(436,000)
Customer deposits4,000–4,000
Net cash used in operating activities(23,893,000)–(23,893,000)
Cash flows from investing activities:
Purchases of equipment(797,000)–(797,000)
Net cash used in investing activities(797,000)–(797,000)
Cash flows from financing activities:
Proceeds from the issuance of common stock in registered direct offering, net of offering costs13,971,000–13,971,000
Proceeds from the issuance of common stock in public offering, net of offering costs1,602,000–1,602,000
Proceeds from revolving line of credit8,450,000–8,450,000
Payment of revolving line of credit(3,561,000)–(3,561,000)
Net cash provided by financing activities20,462,000–20,462,000
-
Net change in cash(4,228,000)–(4,228,000)
Cash, beginning of period4,713,000–4,713,000
Cash, end of period$485,000$–$485,000
Supplemental Disclosures of Non-Cash Investing and Financing Activities:
Common stock issued for vested RSUs$21,000$–$21,000
Warrants issued in connection with borrowing agreements, recorded as debt issuance cost$–$253,000(e)$253,000
Supplemental cash flow information:
Interest paid$151,000$-$151,000

NOTE 16 –QUARTERLY FINANCIAL SUMMARY (Unaudited)

The following tables present the impact of the restatement for the quarters ended March 31, 2024, December 31, 2023, September 30, 2023, June 30, 2023, March 31, 2023, December 31, 2022, September 30, 2022, June 30, 2022, March 31, 2022, December 31, 2021 and September 30, 2021 (collectively, the “Restated Quarters”). These tables also include financial information pertaining to the quarter ended June 30, 2024.

The unaudited condensed consolidated interim financial statements reflect all adjustments, consisting only of normal and recurring items, necessary to present fairly the Company’s financial position, the results of operations, statements of cash flows, and changes in stockholder’s equity for the quarters ended within the Restated Quarters.

The nature of the restatement adjustments and their impact on previously reported unaudited condensed consolidated interim financial statements are as follows:

(a) Inventories. The Company did not properly evaluate its calculation of its excess and obsolescence reserve on its finished goods and raw materials inventories, resulting in an overstatement of inventories and an understatement of cost of sales. In addition, certain inventory components were not properly recorded at the lower of cost or net realizable value, resulting in an overstatement of inventories and an understatement of cost of sales. Further, certain loaner service packs and consigned inventory were not reconciled in a timely manner, resulting in an overstatement of inventories and an understatement of cost of sales. Additionally, the Company did not properly present inventory write downs on the consolidated statement of cash flows resulting in an understatement of inventory write downs and corresponding overstatement of changes in inventories on the consolidated statement of cash flows.

(b) Revenue. The Company did not properly recognize revenue in the periods which the related performance obligations were satisfied for a certain contract with a customer. Additionally, the Company improperly recorded accounts receivable from the same contract with a customer as a reduction to its accounts payable owed to the customer prior to the right of offset conditions under ASC 210-20 being met. As a result, revenues, accounts receivable, and accounts payable were misstated.

(c) Expense classification. The Company improperly recorded various inventory write downs to research and development expenses although such expenses did not meet the classification criteria for research and development under ASC 730, resulting in an overstatement of research and development expenses and a corresponding understatement of cost of sales.

(d) Other. The Company had various clearing accounts that were not reconciled in a timely manner, resulting in misstatements of accounts payable, inventories and cost of sales.

(e) Product warranty liability. The Company did not include certain product warranty-related expenses within the proper period in its calculation of its product warranty reserve estimate, resulting in an understatement of accrued expenses, an understatement of accounts payable and an understatement of cost of sales.

(f) Cash flow presentation of debt issuance cost in the form of issued Company stock warrants. The Company erroneously presented debt issuance cost incurred in conjunction with credit facility arrangements as fair value of warrants issued, an adjustment to reconcile net loss to net cash used in operating activities in the Company’s consolidated statement of cash flows. As debt issuance costs are recorded as a current asset, the presentation overstated adjustments to reconcile net loss to cash used in operating activities and understated the change in other assets in the consolidated statement of cash flows. Additionally, the Company improperly omitted the non-cash disclosure related to the issuance of warrants within the supplemental disclosures of non-cash investing and financing activities.

Summarized Financial Items

The following tables set forth summarized quarterly financial information of the Restated Quarters, including the effects of the restatement on our previously reported consolidated statements of operations, and the quarter ended June 30, 2024.

June 30, 2024March 31, 2024December 31, 2023September 30, 2023
Restated · Restated · Restated
Revenues$13,377,000$14,457,000$18,203,000$14,787,000
Gross profit3,592,0004,025,0005,381,0004,235,000
Operating loss(1,811,000)(2,572,000)(447,000)(1,785,000)
Net loss(2,244,000)(3,005,000)(896,000)(2,188,000)
Net loss per share – basic and diluted$(0.13)$(0.18)$(0.06)$(0.13)
June 30, 2023March 31, 2023December 31, 2022September 30, 2022
RestatedRestatedRestatedRestated
Revenues$16,403,000$15,087,000$17,158,000$17,840,000
Gross profit3,601,0004,677,0003,993,0003,619,000
Operating loss(1,832,000)(1,229,000)(1,419,000)(1,932,000)
Net loss(2,200,000)(1,487,000)(1,796,000)(2,260,000)
Net loss per share – basic and diluted$(0.13)$(0.10)$(0.11)$(0.14)
June 30, 2022March 31, 2022December 31, 2021September 30, 2021
RestatedRestatedRestatedRestated
Revenues$15,195,000$13,177,000$7,690,000$6,271,000
Gross profit2,714,0001,601,000187,0001,105,000
Operating loss(2,672,000)(3,841,000)(5,348,000)(4,360,000)
Net loss(2,838,000)(3,893,000)(5,379,000)(4,363,000)
Net loss per share – basic and diluted$(0.18)$(0.24)$(0.33)$(0.32)

Quarterly Financial Summary

The net impact of the restatement on our quarterly and year-to-date unaudited condensed financial statements is as follows:

March 31,December 31,September 30,
202420232023
RestatedRestatedRestated
ASSETS
Current assets:
Cash$1,250,000$1,584,000$1,139,000
Accounts receivable10,468,00012,726,00010,840,000
Inventories, net17,362,00015,554,00016,591,000
Other current assets840,000942,0001,053,000
Total current assets29,920,00030,806,00029,623,000
Right of use asset2,291,0002,482,0002,670,000
Property, plant and equipment, net1,705,0001,680,0001,747,000
Other assets118,000119,000119,000
Total assets$34,034,000$35,087,000$34,159,000
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable$11,394,000$10,361,000$10,202,000
Accrued expenses3,900,0003,350,0003,782,000
Line of credit13,645,00013,575,00011,986,000
Deferred revenue343,000310,000336,000
Customer deposits18,000232,00017,000
Finance leases payable, current portion153,000150,000147,000
Office leases payable, current portion712,000689,000667,000
Accrued interest136,000130,000102,000
Total current liabilities30,301,00028,797,00027,239,000
Long term liabilities:
Finance leases payable, less current portion153,000191,000229,000
Office leases payable, less current portion1,511,0001,698,0001,880,000
Total liabilities31,965,00030,686,00029,348,000
Stockholders’ equity:
Preferred stock, $0.001 par value; 500,000 shares authorized; none issued and outstanding---
Common stock, $0.001 par value; 30,000,000 shares authorized; 16,599,683, 16,532,275 and 16,478,237 shares issued and outstanding at March 31, 2024, December 31, 2023 and September 30, 2023, respectively17,00017,00016,000
Additional paid-in capital99,520,00098,847,00098,362,000
Accumulated deficit(97,468,000)(94,463,000)(93,567,000)
Total stockholders’ equity2,069,0004,401,0004,811,000
Total liabilities and stockholders’ equity$34,034,000$35,087,000$34,159,000
March 31,December 31,September 30,
202320222022
RestatedRestatedRestated
ASSETS
Current assets:
Cash$790,000$157,000$306,000
Accounts receivable9,881,00010,507,00011,596,000
Inventories, net18,859,00017,449,00016,935,000
Other current assets775,000884,0001,308,000
Total current assets30,305,00028,997,00030,145,000
Right of use asset3,035,0002,601,0002,558,000
Property, plant and equipment, net1,724,0001,561,0001,758,000
Other assets119,000115,00042,000
Total assets$35,183,000$33,274,000$34,503,000
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable$10,855,000$12,837,000$13,505,000
Accrued expenses2,604,0002,298,0002,228,000
Line of credit10,491,0006,811,0005,651,000
Deferred revenue–81,000347,000
Customer deposits135,00029,00010,000
Finance leases payable, current portion140,00064,00013,000
Office leases payable, current portion616,000542,000523,000
Accrued interest3,0001,0002,000
Total current liabilities24,844,00022,663,00022,279,000
Long term liabilities:
Finance leases payable, less current portion311,000172,00055,000
Office leases payable, less current portion2,223,0002,079,0002,222,000
Total liabilities27,378,00024,914,00024,556,000
Stockholders’ equity:
Preferred stock, $0.001 par value; 500,000 shares authorized; none issued and outstanding---
Common stock, $0.001 par value; 30,000,000 shares authorized; 16,156,432, 16,029,478 and 15,998,336 shares issued and outstanding at March 31, 2023, December 31, 2022 and September 30, 2022, respectively16,00016,00016,000
Additional paid-in capital96,968,00096,036,00095,827,000
Accumulated deficit(89,179,000)(87,692,000)(85,896,000)
Total stockholders’ equity7,805,0008,360,0009,947,000
Total liabilities and stockholders’ equity$35,183,000$33,274,000$34,503,000
March 31,December 31,September 30,
202220212021
RestatedRestatedRestated
ASSETS
Current assets:
Cash$3,804,000$7,855,000$15,737,000
Accounts receivable9,508,0005,184,0004,511,000
Inventories, net19,297,00018,090,00012,655,000
Other current assets577,000868,0001,026,000
Total current assets33,186,00031,997,00033,929,000
Right of use asset2,711,0002,821,0002,929,000
Property, plant and equipment, net1,588,0001,627,0001,471,000
Other assets89,00089,00089,000
Total assets$37,574,000$36,534,000$38,418,000
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable$13,361,000$9,239,000$9,298,000
Accrued expenses2,142,0002,233,0001,908,000
Line of credit3,500,0003,500,000–
Deferred revenue313,000140,000127,000
Customer deposits690,000–322,000
Office leases payable, current portion486,000469,000452,000
Accrued interest2,0003,0003,000
Total current liabilities20,494,00015,584,00012,110,000
Long term liabilities:
Office leases payable, less current portion2,493,0002,621,0002,745,000
Total liabilities22,987,00018,205,00014,855,000
Stockholders’ equity:
Preferred stock, $0.001 par value; 500,000 shares authorized; none issued and outstanding---
Common stock, $0.001 par value; 30,000,000 shares authorized; 15,992,080, 15,987,502 and 15,987,502 shares issued and outstanding at March 31, 2022, December 31, 2021 and September 30, 2021, respectively16,00016,00016,000
Additional paid-in capital95,369,00095,217,00095,073,000
Accumulated deficit(80,798,000)(76,904,000)(71,526,000)
Total stockholders’ equity14,587,00018,329,00023,563,000
Total liabilities and stockholders’ equity$37,574,000$36,534,000$38,418,000
As previously reportedRestatement adjustmentsReferenceAs restated
ASSETS
Current assets:
Cash$1,250,000$–$1,250,000
Accounts receivable (b)10,404,00064,000(b)10,468,000
Inventories, net (a)(d)20,174,000(2,812,000)(a) (d)17,362,000
Other current assets840,000-840,000
Total current assets32,668,000(2,748,000)29,920,000
Right of use asset2,291,000–2,291,000
Property, plant and equipment, net1,705,000–1,705,000
Other assets118,000–118,000
Total assets$36,782,000$(2,748,000)$34,034,000
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable (b)(d)(e)$11,050,000$344,000(b) (d) (e)$11,394,000
Accrued expenses (e)3,645,000255,000(e)3,900,000
Line of credit13,645,000–13,645,000
Deferred revenue343,000–343,000
Customer deposits18,000–18,000
Finance leases payable, current portion153,000–153,000
Office leases payable, current portion712,000–712,000
Accrued interest136,000–136,000
Total current liabilities29,702,000599,00030,301,000
Long term liabilities:
Finance leases payable, less current portion153,000–153,000
Office leases payable, less current portion1,511,000–1,511,000
Total liabilities31,366,000599,00031,965,000
Stockholders’ equity:
Preferred stock, $0.001 par value; 500,000 shares authorized; none issued and outstanding---
Common stock, $0.001 par value; 30,000,000 shares authorized; 16,599,683 shares issued and outstanding17,000–17,000
Additional paid-in capital99,520,000–99,520,000
Accumulated deficit (a)(d)(e)(94,121,000)(3,347,000)(a) (d) (e)(97,468,000)
Total stockholders’ equity5,416,000(3,347,000)2,069,000
Total liabilities and stockholders’ equity$36,782,000$(2,748,000)$34,034,000
As previously reportedRestatement adjustmentsReferenceAs restated
ASSETS
Current assets:
Cash$1,584,000$–$1,584,000
Accounts receivable (b)12,579,000147,000(b)12,726,000
Inventories, net (a)(d)18,283,000(2,729,000)(a) (d)15,554,000
Other current assets942,000-942,000
Total current assets33,388,000(2,582,000)30,806,000
Right of use asset2,482,000–2,482,000
Property, plant and equipment, net1,680,000–1,680,000
Other assets119,000–119,000
Total assets$37,669,000$(2,582,000)$35,087,000
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable (b)(d)(e)$10,021,000$340,000(b) (d) (e)$10,361,000
Accrued expenses (e)3,290,00060,000(e)3,350,000
Line of credit13,575,000–13,575,000
Deferred revenue310,000–310,000
Customer deposits232,000–232,000
Finance leases payable, current portion150,000–150,000
Office leases payable, current portion689,000–689,000
Accrued interest130,000–130,000
Total current liabilities28,397,000400,00028,797,000
Long term liabilities:
Finance leases payable, less current portion191,000–191,000
Office leases payable, less current portion1,698,000–1,698,000
Total liabilities30,286,000400,00030,686,000
Stockholders’ equity:
Preferred stock, $0.001 par value; 500,000 shares authorized; none issued and outstanding---
Common stock, $0.001 par value; 30,000,000 shares authorized; 16,532,275 shares issued and outstanding17,000–17,000
Additional paid-in capital98,847,000–98,847,000
Accumulated deficit (a)(d)(e)(91,481,000)(2,982,000)(a) (d) (e)(94,463,000)
Total stockholders’ equity7,383,000(2,982,000)4,401,000
Total liabilities and stockholders’ equity$37,669,000$(2,582,000)$35,087,000
As previously reportedRestatement adjustmentsReferenceAs restated
ASSETS
Current assets:
Cash$1,139,000$–$1,139,000
Accounts receivable (b)10,699,000141,000(b)10,840,000
Inventories, net (a)(d)19,495,000(2,904,000)(a) (d)16,591,000
Other current assets1,053,000-1,053,000
Total current assets32,386,000(2,763,000)29,623,000
Right of use asset2,670,000–2,670,000
Property, plant and equipment, net1,747,000–1,747,000
Other assets119,000–119,000
Total assets$36,922,000$(2,763,000)$34,159,000
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable (d)$10,065,000$137,000(d)$10,202,000
Accrued expenses3,782,000–3,782,000
Line of credit11,986,000–11,986,000
Deferred revenue336,000–336,000
Customer deposits17,000–17,000
Finance leases payable, current portion147,000–147,000
Office leases payable, current portion667,000–667,000
Accrued interest102,000–102,000
Total current liabilities27,102,000137,00027,239,000
Long term liabilities:
Finance leases payable, less current portion229,000–229,000
Office leases payable, less current portion1,880,000–1,880,000
Total liabilities29,211,000137,00029,348,000
Stockholders’ equity:
Preferred stock, $0.001 par value; 500,000 shares authorized; none issued and outstanding---
Common stock, $0.001 par value; 30,000,000 shares authorized; 16,478,237 shares issued and outstanding16,000–16,000
Additional paid-in capital98,362,000–98,362,000
Accumulated deficit (a)(b)(d)(90,667,000)(2,900,000)(a) (b) (d)(93,567,000)
Total stockholders’ equity7,711,000(2,900,000)4,811,000
Total liabilities and stockholders’ equity$36,922,000$(2,763,000)$34,159,000
As previously reportedRestatement adjustmentsReferenceAs restated
ASSETS
Current assets:
Cash$790,000$–$790,000
Accounts receivable (b)9,853,00028,000(b)9,881,000
Inventories, net (a)(d)20,959,000(2,100,000)(a) (d)18,859,000
Other current assets775,000-775,000
Total current assets32,377,000(2,072,000)30,305,000
Right of use asset3,035,000–3,035,000
Property, plant and equipment, net1,724,000–1,724,000
Other assets119,000–119,000
Total assets$37,255,000$(2,072,000)$35,183,000
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable (b)$10,827,000$28,000(b)$10,855,000
Accrued expenses2,604,000–2,604,000
Line of credit10,491,000–10,491,000
Customer deposits135,000–135,000
Finance leases payable, current portion140,000–140,000
Office leases payable, current portion616,000–616,000
Accrued interest3,000–3,000
Total current liabilities24,816,00028,00024,844,000
Long term liabilities:
Finance leases payable, less current portion311,000–311,000
Office leases payable, less current portion2,223,000–2,223,000
Total liabilities27,350,00028,00027,378,000
Stockholders’ equity:
Preferred stock, $0.001 par value; 500,000 shares authorized; none issued and outstanding---
Common stock, $0.001 par value; 30,000,000 shares authorized; 16,156,432 shares issued and outstanding16,000–16,000
Additional paid-in capital96,968,000–96,968,000
Accumulated deficit (a)(d)(87,079,000)(2,100,000)(a) (d)(89,179,000)
Total stockholders’ equity9,905,000(2,100,000)7,805,000
Total liabilities and stockholders’ equity$37,255,000$(2,072,000)$35,183,000
As previously reportedRestatement adjustmentsReferenceAs restated
ASSETS
Current assets:
Cash$157,000$–$157,000
Accounts receivable (b)10,467,00040,000(b)10,507,000
Inventories, net (a)(d)19,507,000(2,058,000)(a) (d)17,449,000
Other current assets884,000-884,000
Total current assets31,015,000(2,018,000)28,997,000
Right of use asset2,601,000–2,601,000
Property, plant and equipment, net1,561,000–1,561,000
Other assets115,000–115,000
Total assets$35,292,000$(2,018,000)$33,274,000
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable (b)$12,797,000$40,000(b)$12,837,000
Accrued expenses2,298,000–2,298,000
Line of credit6,811,000–6,811,000
Deferred revenue81,000–81,000
Customer deposits29,000–29,000
Finance leases payable, current portion64,000–64,000
Office leases payable, current portion542,000–542,000
Accrued interest1,000–1,000
Total current liabilities22,623,00040,00022,663,000
Long term liabilities:
Finance leases payable, less current portion172,000–172,000
Office leases payable, less current portion2,079,000–2,079,000
Total liabilities24,874,00040,00024,914,000
Stockholders’ equity:
Preferred stock, $0.001 par value; 500,000 shares authorized; none issued and outstanding–––
Common stock, $0.001 par value; 30,000,000 shares authorized; 16,029,478 shares issued and outstanding16,000–16,000
Additional paid-in capital96,036,000–96,036,000
Accumulated deficit (a)(d)(85,634,000)(2,058,000)(a) (d)(87,692,000)
Total stockholders’ equity10,418,000(2,058,000)8,360,000
Total liabilities and stockholders’ equity$35,292,000$(2,018,000)$33,274,000
As previously reportedRestatement adjustmentsReferenceAs restated
ASSETS
Current assets:
Cash$306,000$–$306,000
Accounts receivable11,596,000-11,596,000
Inventories, net (a)(d)18,878,000(1,943,000)(a) (d)16,935,000
Other current assets1,308,000-1,308,000
Total current assets32,088,000(1,943,000)30,145,000
Right of use asset2,558,000–2,558,000
Property, plant and equipment, net1,758,000–1,758,000
Other assets42,000–42,000
Total assets$36,446,000$(1,943,000)$34,503,000
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable$13,505,000$–$13,505,000
Accrued expenses2,228,000–2,228,000
Line of credit5,651,000–5,651,000
Deferred revenue347,000–347,000
Customer deposits10,000–10,000
Finance leases payable, current portion13,000–13,000
Office leases payable, current portion523,000–523,000
Accrued interest2,000–2,000
Total current liabilities22,279,000–22,279,000
Long term liabilities:
Finance leases payable, less current portion55,000–55,000
Office leases payable, less current portion2,222,000–2,222,000
Total liabilities24,556,000–24,556,000
Stockholders’ equity:
Preferred stock, $0.001 par value; 500,000 shares authorized; none issued and outstanding---
Common stock, $0.001 par value; 30,000,000 shares authorized; 15,998,336 shares issued and outstanding16,000–16,000
Additional paid-in capital95,827,000–95,827,000
Accumulated deficit (a)(d)(83,953,000)(1,943,000)(a) (d)(85,896,000)
Total stockholders’ equity11,890,000(1,943,000)9,947,000
Total liabilities and stockholders’ equity$36,446,000$(1,943,000)$34,503,000
As previously reportedRestatement adjustmentsReferenceAs restated
ASSETS
Current assets:
Cash$3,804,000$–$3,804,000
Accounts receivable9,508,000-9,508,000
Inventories, net (a) (d)20,934,000(1,637,000)(a) (d)19,297,000
Other current assets577,000-577,000
Total current assets34,823,000(1,637,000)33,186,000
Right of use asset2,711,000–2,711,000
Property, plant and equipment, net1,588,000–1,588,000
Other assets89,000–89,000
Total assets$39,211,000$(1,637,000)$37,574,000
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable$13,361,000$–$13,361,000
Accrued expenses2,142,000–2,142,000
Line of credit3,500,000–3,500,000
Deferred revenue313,000–313,000
Customer deposits690,000–690,000
Office leases payable, current portion486,000–486,000
Accrued interest2,000–2,000
Total current liabilities20,494,000–20,494,000
Long term liabilities:
Office leases payable, less current portion2,493,000–2,493,000
Total liabilities22,987,000–22,987,000
Stockholders’ equity:
Preferred stock, $0.001 par value; 500,000 shares authorized; none issued and outstanding---
Common stock, $0.001 par value; 30,000,000 shares authorized; 15,992,080 shares issued and outstanding16,000–16,000
Additional paid-in capital95,369,000–95,369,000
Accumulated deficit(a) (d)(79,161,000)(1,637,000)(a) (d)(80,798,000)
Total stockholders’ equity16,224,000(1,637,000)14,587,000
Total liabilities and stockholders’ equity$39,211,000$(1,637,000)$37,574,000
As previously reportedRestatement adjustmentsReferenceAs restated
ASSETS
Current assets:
Cash$7,855,000$–$7,855,000
Accounts receivable5,184,000-5,184,000
Inventories, net (a) (d)19,583,000(1,493,000)(a) (d)18,090,000
Other current assets868,000-868,000
Total current assets33,490,000(1,493,000)31,997,000
Right of use asset2,821,000–2,821,000
Property, plant and equipment, net1,627,000–1,627,000
Other assets89,000–89,000
Total assets$38,027,000$(1,493,000)$36,534,000
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable$9,239,000$–$9,239,000
Accrued expenses2,233,000–2,233,000
Line of credit3,500,000–3,500,000
Deferred revenue140,000–140,000
Office leases payable, current portion469,000–469,000
Accrued interest3,000–3,000
Total current liabilities15,584,000–15,584,000
Long term liabilities:
Office leases payable, less current portion2,621,000–2,621,000
Total liabilities18,205,000–18,205,000
Stockholders’ equity:
Preferred stock, $0.001 par value; 500,000 shares authorized; none issued and outstanding---
Common stock, $0.001 par value; 30,000,000 shares authorized; 15,987,502 shares issued and outstanding16,000–16,000
Additional paid-in capital95,217,000–95,217,000
Accumulated deficit (a) (d)(75,411,000)(1,493,000)(a) (d)(76,904,000)
Total stockholders’ equity19,822,000(1,493,000)18,329,000
Total liabilities and stockholders’ equity$38,027,000$(1,493,000)$36,534,000
As previously reportedRestatement adjustmentsReferenceAs restated
ASSETS
Current assets:
Cash$15,737,000$–$15,737,000
Accounts receivable4,511,000-4,511,000
Inventories, net (a)(d)13,846,000(1,191,000)(a) (d)12,655,000
Other current assets1,026,000-1,026,000
Total current assets35,120,000(1,191,000)33,929,000
Right of use asset2,929,000–2,929,000
Property, plant and equipment, net1,471,000–1,471,000
Other assets89,000–89,000
Total assets$39,609,000$(1,191,000)$38,418,000
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable$9,298,000$–$9,298,000
Accrued expenses1,908,000–1,908,000
Deferred revenue127,000–127,000
Customer deposits322,000–322,000
Office leases payable, current portion452,000–452,000
Accrued interest3,000–3,000
Total current liabilities12,110,000–12,110,000
Long term liabilities:
Office leases payable, less current portion2,745,000–2,745,000
Total liabilities14,855,000–14,855,000
Stockholders’ equity:
Preferred stock, $0.001 par value; 500,000 shares authorized; none issued and outstanding---
Common stock, $0.001 par value; 30,000,000 shares authorized; 15,987,502 shares issued and outstanding16,000–16,000
Additional paid-in capital95,073,000–95,073,000
Accumulated deficit(70,335,000)(1,191,000)(a) (d)(71,526,000)
Total stockholders’ equity24,754,000(1,191,000)23,563,000
Total liabilities and stockholders’ equity$39,609,000$(1,191,000)$38,418,000
March 31, 2024 · December 31, 2023 · September 30, 2023
Three months endedNine months endedThree months endedSix months endedThree months ended
RestatedRestatedRestatedRestatedRestated
Revenues$14,457,000$47,447,000$18,203,000$32,990,000$14,787,000
Cost of sales10,432,00033,806,00012,822,00023,374,00010,552,000
Gross profit4,025,00013,641,0005,381,0009,616,0004,235,000
Operating expenses:
Selling and administrative5,311,00014,629,0004,593,0009,318,0004,725,000
Research and development1,286,0003,816,0001,235,0002,530,0001,295,000
Total operating expenses6,597,00018,445,0005,828,00011,848,0006,020,000
Operating loss(2,572,000)(4,804,000)(447,000)(2,232,000)(1,785,000)
Other income (expense):
Interest income (expense), net(433,000)(1,285,000)(449,000)(852,000)(403,000)
Net loss$(3,005,000)$(6,089,000)$(896,000)$(3,084,000)$(2,188,000)
Net loss per share - basic and diluted$(0.18)$(0.37)$(0.06)$(0.19)$(0.13)
Weighted average number of common shares outstanding - basic and diluted16,538,99816,510,04616,516,70016,495,72716,474,754
March 31, 2023 · December 31, 2022 · September 30, 2022
Three months endedNine months endedThree months endedSix months endedThree months ended
RestatedRestatedRestatedRestatedRestated
Revenues$15,087,000$50,085,000$17,158,000$34,998,000$17,840,000
Cost of sales10,410,00037,796,00013,165,00027,386,00014,221,000
Gross profit4,677,00012,289,0003,993,0007,612,0003,619,000
Operating expenses:
Selling and administrative4,724,00013,510,0004,250,0008,786,0004,536,000
Research and development1,182,0003,359,0001,162,0002,177,0001,015,000
Total operating expenses5,906,00016,869,0005,412,00010,963,0005,551,000
Operating loss(1,229,000)(4,580,000)(1,419,000)(3,351,000)(1,932,000)
Other income (expense):
Other income–8,0008,0008,000–
Interest income (expense), net(258,000)(971,000)(385,000)(713,000)(328,000)
Net loss$(1,487,000)$(5,543,000)$(1,796,000)$(4,056,000)$(2,260,000)
Net loss per share - basic and diluted$(0.10)$(0.35)$(0.11)$(0.25)$(0.14)
Weighted average number of common shares outstanding - basic and diluted16,048,05416,021,65316,020,18316,008,74015,997,296
March 31, 2022 · December 31, 2021 · September 30, 2021
Three months endedNine months endedThree months endedSix months endedThree months ended
RestatedRestatedRestatedRestatedRestated
Revenues$13,177,000$27,138,000$7,690,000$13,961,000$6,271,000
Cost of sales11,576,00024,245,0007,503,00012,669,0005,166,000
Gross profit1,601,0002,893,000187,0001,292,0001,105,000
Operating expenses:
Selling and administrative3,904,00011,402,0004,000,0007,498,0003,498,000
Research and development1,538,0005,040,0001,535,0003,502,0001,967,000
Total operating expenses5,442,00016,442,0005,535,00011,000,0005,465,000
Operating loss(3,841,000)(13,549,000)(5,348,000)(9,708,000)(4,360,000)
Other income (expense):
Interest income (expense), net(52,000)(86,000)(31,000)(34,000)(3,000)
Net loss$(3,893,000)$(13,635,000)$(5,379,000)$(9,742,000)$(4,363,000)
Net loss per share - basic and diluted$(0.24)$(0.89)$(0.33)$(0.65)$(0.32)
Weighted average number of common shares outstanding - basic and diluted15,988,92615,254,98315,987,50214,895,98913,804,475
As previously reportedRestatement adjustmentsReferenceAs restated
Revenues$14,457,000$–$14,457,000
Cost of sales (a)(e)10,067,000365,000(a) (e)10,432,000
Gross profit4,390,000(365,000)4,025,000
Operating expenses:
Selling and administrative5,311,000–5,311,000
Research and development1,286,000–1,286,000
Total operating expenses6,597,000–6,597,000
Operating loss(2,207,000)(365,000)(2,572,000)
Other income (expense):
Interest income (expense), net(433,000)–(433,000)
Net loss$(2,640,000)$(365,000)$(3,005,000)
Net loss per share - basic and diluted$(0.16)$(0.02)$(0.18)
Weighted average number of common shares outstanding - basic and diluted16,538,99816,538,99816,538,998
As previously reportedRestatement adjustmentsReferenceAs restated
Revenues (b)$18,344,000$(141,000)(b)$18,203,000
Cost of sales (a)(c)(d)(e)12,676,000146,000(a) (c) (d) (e)12,822,000
Gross profit5,668,000(287,000)5,381,000
Operating expenses:
Selling and administrative4,593,000–4,593,000
Research and development (c)1,440,000(205,000)(c)1,235,000
Total operating expenses6,033,000(205,000)5,828,000
Operating loss(365,000)(82,000)(447,000)
Other income (expense):
Interest income (expense), net(449,000)–(449,000)
Net loss$(814,000)$(82,000)$(896,000)
Net loss per share - basic and diluted$(0.05)$(0.01)$(0.06)
Weighted average number of common shares outstanding - basic and diluted16,516,70016,516,70016,516,700
As previously reportedRestatement adjustmentsReferenceAs restated
Revenues(b)$14,797,000$(10,000)(b)$14,787,000
Cost of sales(a)10,486,00066,000(a)10,552,000
Gross profit4,311,000(76,000)4,235,000
Operating expenses:
Selling and administrative4,725,000–4,725,000
Research and development1,295,000–1,295,000
Total operating expenses6,020,000–6,020,000
Operating loss(1,709,000)(76,000)(1,785,000)
Other income (expense):
Interest income (expense), net(403,000)–(403,000)
Net loss$(2,112,000)$(76,000)$(2,188,000)
Net loss per share - basic and diluted$(0.13)$(0.00)$(0.13)
Weighted average number of common shares outstanding - basic and diluted16,474,75416,474,75416,474,754
As previously reportedRestatement adjustmentsReferenceAs restated
Revenues$15,087,000$–$15,087,000
Cost of sales(a)(d)10,368,00042,000(a) (d)10,410,000
Gross profit4,719,000(42,000)4,677,000
Operating expenses:
Selling and administrative4,724,000–4,724,000
Research and development1,182,000–1,182,000
Total operating expenses5,906,000–5,906,000
Operating loss(1,187,000)(42,000)(1,229,000)
Other income (expense):
Interest income (expense), net(258,000)–(258,000)
Net loss$(1,445,000)$(42,000)$(1,487,000)
Net loss per share - basic and diluted$(0.09)$(0.01)$(0.10)
Weighted average number of common shares outstanding - basic and diluted16,048,05416,048,05416,048,054
As previously reportedRestatement adjustmentsReferenceAs restated
Revenues$17,158,000$–$17,158,000
Cost of sales (a)(d)13,050,000115,000(a) (d)13,165,000
Gross profit4,108,000(115,000)3,993,000
Operating expenses:
Selling and administrative4,250,000–4,250,000
Research and development1,162,000–1,162,000
Total operating expenses5,412,000–5,412,000
Operating loss(1,304,000)(115,000)(1,419,000)
Other income (expense):
Other income8,000–8,000
Interest income (expense), net(385,000)–(385,000)
Net loss$(1,681,000)$(115,000)$(1,796,000)
Net loss per share - basic and diluted$(0.10)$(0.01)$(0.11)
Weighted average number of common shares outstanding - basic and diluted16,020,18316,020,18316,020,183
As previously reportedRestatement adjustmentsReferenceAs restated
Revenues$17,840,000$–$17,840,000
Cost of sales (a)(c)(d)13,892,000329,000(a) (c) (d)14,221,000
Gross profit3,948,000(329,000)3,619,000
Operating expenses:
Selling and administrative4,536,000–4,536,000
Research and development (c)1,223,000(208,000)(c)1,015,000
Total operating expenses5,759,000(208,000)5,551,000
Operating loss(1,811,000)(121,000)(1,932,000)
Other income (expense):
Interest income (expense), net(328,000)–(328,000)
Net loss$(2,139,000)$(121,000)$(2,260,000)
Net loss per share - basic and diluted$(0.13)$(0.01)$(0.14)
Weighted average number of common shares outstanding - basic and diluted15,997,29615,997,29615,997,296
As previously reportedRestatement adjustmentsReferenceAs restated
Revenues$13,177,000$–$13,177,000
Cost of sales (a)(c)(d)11,257,000319,000(a) (c) (d)11,576,000
Gross profit1,920,000(319,000)1,601,000
Operating expenses:
Selling and administrative3,904,000–3,904,000
Research and development (c)1,713,000(175,000)(c)1,538,000
Total operating expenses5,617,000(175,000)5,442,000
Operating loss(3,697,000)(144,000)(3,841,000)
Other income (expense):
Interest income (expense), net(52,000)–(52,000)
Net loss$(3,749,000)$(144,000)$(3,893,000)
Net loss per share - basic and diluted$(0.23)$(0.01)$(0.24)
Weighted average number of common shares outstanding - basic and diluted15,988,92615,988,92615,988,926
As previously reportedRestatement adjustmentsReferenceAs restated
Revenues$7,690,000$–$7,690,000
Cost of sales (a)(c)(d)6,648,000855,000(a) (c) (d)7,503,000
Gross profit1,042,000(855,000)187,000
Operating expenses:
Selling and administrative4,000,000–4,000,000
Research and development (c)2,088,000(553,000)(c)1,535,000
Total operating expenses6,088,000(553,000)5,535,000
Operating loss(5,046,000)(302,000)(5,348,000)
Other income (expense):
Interest income (expense), net(31,000)–(31,000)
Net loss$(5,077,000)$(302,000)$(5,379,000)
Net loss per share - basic and diluted$(0.32)$(0.01)$(0.33)
Weighted average number of common shares outstanding - basic and diluted15,987,50215,987,50215,987,502
As previously reportedRestatement adjustmentsReferenceAs restated
Revenues$6,271,000$–$6,271,000
Cost of sales (a)(d)4,933,000233,000(a) (d)5,166,000
Gross profit1,338,000(233,000)1,105,000
Operating expenses:
Selling and administrative3,498,000–3,498,000
Research and development1,967,000–1,967,000
Total operating expenses5,465,000–5,465,000
Operating loss(4,127,000)(233,000)(4,360,000)
Other income (expense):
Interest income (expense), net(3,000)–(3,000)
Net loss$(4,130,000)$(233,000)$(4,363,000)
Net loss per share - basic and diluted$(0.30)$(0.02)$(0.32)
Weighted average number of common shares outstanding - basic and diluted13,804,47513,804,47513,804,475
As previously reportedRestatement adjustmentsReferenceAs restated
Revenues (b)$33,141,000$(151,000)(b)$32,990,000
Cost of sales (a)(c)(d)(e)23,162,000212,000(a) (c) (d) (e)23,374,000
Gross profit9,979,000(363,000)9,616,000
Operating expenses:
Selling and administrative9,318,000–9,318,000
Research and development (c)2,735,000(205,000)(c)2,530,000
Total operating expenses12,053,000(205,000)11,848,000
Operating loss(2,074,000)(158,000)(2,232,000)
Other income (expense):
Interest income (expense), net(852,000)–(852,000)
Net loss$(2,926,000)$(158,000)$(3,084,000)
Net loss per share - basic and diluted$(0.18)$(0.01)$(0.19)
Weighted average number of common shares outstanding - basic and diluted16,495,72716,495,72716,495,727
As previously reportedRestatement adjustmentsReferenceAs restated
Revenues$34,998,000$–$34,998,000
Cost of sales (a)(c)(d)26,942,000444,000(a) (c) (d)27,386,000
Gross profit8,056,000(444,000)7,612,000
Operating expenses:
Selling and administrative8,786,000–8,786,000
Research and development (c)2,385,000(208,000)(c)2,177,000
Total operating expenses11,171,000(208,000)10,963,000
Operating loss(3,115,000)(236,000)(3,351,000)
Other income (expense):
Other income8,000–8,000
Interest income (expense), net(713,000)–(713,000)
Net loss$(3,820,000)$(236,000)$(4,056,000)
Net loss per share - basic and diluted$(0.24)$(0.01)$(0.25)
Weighted average number of common shares outstanding - basic and diluted16,008,74016,008,74016,008,740
As previously reportedRestatement adjustmentsReferenceAs restated
Revenues$13,961,000$–$13,961,000
Cost of sales (a)(c)(d)11,581,0001,088,000(a) (c) (d)12,669,000
Gross profit2,380,000(1,088,000)1,292,000
Operating expenses:
Selling and administrative7,498,000–7,498,000
Research and development (c)4,055,000(553,000)(c)3,502,000
Total operating expenses11,553,000(553,000)11,000,000
Operating loss(9,173,000)(535,000)(9,708,000)
Other income (expense):
Interest income (expense), net(34,000)–(34,000)
Net loss$(9,207,000)$(535,000)$(9,742,000)
Net loss per share - basic and diluted$(0.62)$(0.03)$(0.65)
Weighted average number of common shares outstanding - basic and diluted14,895,98914,895,98914,895,989
As previously reportedRestatement adjustmentsReferenceAs restated
Revenues (b)$47,598,000$(151,000)(b)$47,447,000
Cost of sales (a)(c)(d)(e)33,229,000577,000(a) (c) (d) (e)33,806,000
Gross profit14,369,000(728,000)13,641,000
Operating expenses:
Selling and administrative14,629,000–14,629,000
Research and development (c)4,021,000(205,000)(c)3,816,000
Total operating expenses18,650,000(205,000)18,445,000
Operating loss(4,281,000)(523,000)(4,804,000)
Other income (expense):
Interest income (expense), net(1,285,000)–(1,285,000)
Net loss$(5,566,000)$(523,000)$(6,089,000)
Net loss per share - basic and diluted$(0.34)$(0.03)$(0.37)
Weighted average number of common shares outstanding - basic and diluted16,510,04616,510,04616,510,046
As previously reportedRestatement adjustmentsReferenceAs restated
Revenues$50,085,000$–$50,085,000
Cost of sales (a)(c)(d)37,310,000486,000(a) (c) (d)37,796,000
Gross profit12,775,000(486,000)12,289,000
Operating expenses:
Selling and administrative13,510,000–13,510,000
Research and development (c)3,567,000(208,000)(c)3,359,000
Total operating expenses17,077,000(208,000)16,869,000
Operating loss(4,302,000)(278,000)(4,580,000)
Other income (expense):
Other income8,000–8,000
Interest income (expense), net(971,000)–(971,000)
Net loss$(5,265,000)$(278,000)$(5,543,000)
Net loss per share - basic and diluted$(0.33)$(0.02)$(0.35)
Weighted average number of common shares outstanding - basic and diluted16,021,65316,021,65316,021,653
As previously reportedRestatement adjustmentsReferenceAs restated
Revenues$27,138,000$–$27,138,000
Cost of sales (a)(c)(d)22,838,0001,407,000(a) (c) (d)24,245,000
Gross profit4,300,000(1,407,000)2,893,000
Operating expenses:
Selling and administrative11,402,000–11,402,000
Research and development (c)5,768,000(728,000)(c)5,040,000
Total operating expenses17,170,000(728,000)16,442,000
Operating loss(12,870,000)(679,000)(13,549,000)
Other income (expense):
Interest income (expense), net(86,000)–(86,000)
Net loss$(12,956,000)$(679,000)$(13,635,000)
Net loss per share - basic and diluted$(0.85)$(0.04)$(0.89)
Weighted average number of common shares outstanding - basic and diluted15,254,98315,254,98315,254,983

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

Common Stock
ReferenceSharesCapital Stock AmountAdditional Paid-in CapitalAccumulated DeficitTotal
Balance, as restated, June 30, 202316,462,215$16,000$98,086,000$(91,379,000)$6,723,000
Activity, as reported16,022–276,000(2,112,000)(1,836,000)
Adjustments (a) (b)(a) (b)–––(76,000)(76,000)
Balance, as restated, September 30, 202316,478,23716,00098,362,000(93,567,000)4,811,000
Activity, as reported54,0381,000485,000(814,000)(328,000)
Adjustments (a)(b)(d)(e)(a) (b) (d) (e)–––(82,000)(82,000)
Balance, as restated, December 31, 202316,532,27517,00098,847,000(94,463,000)4,401,000
Activity, as reported67,408–673,000(2,640,000)(1,967,000)
Adjustments (a) (e)(a) (e)–––(365,000)(365,000)
Balance, as restated, March 31, 202416,599,683$17,000$99,520,000$(97,468,000)$2,069,000
Common Stock
ReferenceSharesCapital Stock AmountAdditional Paid-in CapitalAccumulated DeficitTotal
Balance, as restated, June 30, 202215,996,658$16,000$95,732,000$(83,636,000)$12,112,000
Activity, as reported1,678–95,000(2,139,000)(2,044,000)
Adjustments (a) (d)(a) (d)–––(121,000)(121,000)
Balance, as restated, September 30, 202215,998,33616,00095,827,000(85,896,000)9,947,000
Activity, as reported31,142–209,000(1,681,000)(1,472,000)
Adjustments (a) (d)(a) (d)–––(115,000)(115,000)
Balance, as restated, December 31, 202216,029,47816,00096,036,000(87,692,000)8,360,000
Activity, as reported126,954–932,000(1,445,000)(513,000)
Adjustments (a) (d)(a) (d)–––(42,000)(42,000)
Balance, as restated, March 31, 202316,156,432$16,000$96,968,000$(89,179,000)$7,805,000
Common Stock
ReferenceSharesCapital Stock AmountAdditional Paid-in CapitalAccumulated DeficitTotal
Balance, as restated, June 30, 2021*13,652,164$14,000$79,197,000$(67,163,000)$12,048,000
Activity, as reported2,335,3382,00015,876,000(4,130,000)11,748,000
Adjustments (a) (d)(a) (d)–––(233,000)(233,000)
Balance, as restated, September 30, 202115,987,50216,00095,073,000(71,526,000)23,563,000
Activity, as reported––144,000(5,077,000)(4,933,000)
Adjustments (a) (d)(a) (d)–––(302,000)(302,000)
Balance, as restated, December 31, 202115,987,50216,00095,217,000(76,905,000)18,328,000
Activity, as reported4,578–152,000(3,749,000)(3,597,000)
Adjustments (a) (d)(a) (d)–––(144,000)(144,000)
Balance, as restated, March 31, 202215,992,080$16,000$95,369,000$(80,798,000)$14,587,000
*June 30, 2021 total shareholders’ equity, as restated, reflects the impact of restatement adjustments related to periods prior to the year ended June 30, 2022. The impact of restatement is a decrease of $958,000 to accumulated deficit at June 30, 2021.
Nine months ended March 31, 2024Six months ended December 31, 2023Three months ended September 30, 2023
RestatedRestatedRestated
Cash flows from operating activities:
Net loss$(6,089,000)$(3,084,000)$(2,188,000)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation787,000523,000261,000
Stock-based compensation1,233,000670,000276,000
Amortization of debt issuance costs161,000134,00081,000
Non-cash lease expense448,000296,000146,000
Inventory write downs358,000233,000113,000
Changes in operating assets and liabilities:
Accounts receivable(1,668,000)(3,926,000)(2,040,000)
Inventories(1,562,000)371,000(546,000)
Other assets11,000(65,000)(215,000)
Accounts payable1,522,000489,000330,000
Accrued expenses719,000169,000601,000
Accrued interest134,000128,000100,000
Office leases payable(476,000)(312,000)(152,000)
Deferred revenue212,000179,000205,000
Customer deposits(64,000)150,000(65,000)
Net cash used in operating activities(4,274,000)(4,045,000)(3,093,000)
Cash flows from investing activities:
Purchases of equipment(588,000)(338,000)(181,000)
Net cash used in investing activities(588,000)(338,000)(181,000)
Cash flows from financing activities:
Proceeds from stock option exercises and employee stock purchase plan exercises110,000––
Proceeds from revolving line of credit52,820,00035,868,00018,055,000
Payment of revolving line of credit(49,087,000)(32,205,000)(15,981,000)
Payment of finance leases(110,000)(75,000)(40,000)
Net cash provided by financing activities3,733,0003,588,0002,034,000
Net change in cash(1,129,000)(795,000)(1,240,000)
Cash, beginning of period2,379,0002,379,0002,379,000
Cash, end of period$1,250,000$1,584,000$1,139,000
Supplemental Disclosures of Non-Cash Investing and Financing Activities:
Common stock issued for vested RSUs$222,000$183,000$–
Warrants issued in connection with borrowing agreements, recorded as debt issuance cost$92,000$92,000$–
Supplemental cash flow information:
Interest paid$1,000,000$605,000$223,000
Nine months ended March 31, 2023Six months ended December 31, 2022Three months ended September 30, 2022
RestatedRestatedRestated
Cash flows from operating activities:
Net loss$(5,543,000)$(4,056,000)$(2,260,000)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation647,000371,000172,000
Stock-based compensation539,000304,00095,000
Amortization of debt issuance costs445,000368,000229,000
Non-cash lease expense370,000236,000117,000
Inventory write downs191,00088,00043,000
Changes in operating assets and liabilities:
Accounts receivable(1,272,000)(1,898,000)(2,987,000)
Inventories(4,610,000)(3,097,000)(2,538,000)
Other assets11,000(17,000)(229,000)
Accounts payable4,210,0006,192,0006,860,000
Accrued expenses395,00089,0009,000
Accrued interest2,000–1,000
Office leases payable(379,000)(244,000)(120,000)
Deferred revenue(163,000)(82,000)184,000
Customer deposits(40,000)(146,000)(165,000)
Net cash used in operating activities(5,197,000)(1,892,000)(589,000)
Cash flows from investing activities:
Purchases of equipment(753,000)(344,000)(352,000)
Proceeds from sale of fixed assets8,0008,000–
Net cash used in investing activities(745,000)(336,000)(352,000)
Cash flows from financing activities:
Proceeds from the issuance of common stock in public offering, net of offering costs697,000––
Proceeds from revolving line of credit48,800,00030,550,00012,900,000
Payment of revolving line of credit(43,198,000)(28,628,000)(12,138,000)
Payment of finance leases(52,000)(22,000)–
Net cash provided by financing activities6,247,0001,900,000762,000
Net change in cash305,000(328,000)(179,000)
Cash, beginning of period485,000485,000485,000
Cash, end of period$790,000$157,000$306,000
Supplemental Disclosures of Non-Cash Investing and Financing Activities:
Initial right of use asset recognition$855,000$258,000$78,000
Common stock issued for vested RSUs$114,000$114,000$5,000
Supplemental cash flow information:
Interest paid$524,000$288,000$99,000
Nine months ended March 31, 2022Six months ended December 31, 2021Three months ended September 30, 2021
RestatedRestatedRestated
Cash flows from operating activities:
Net loss$(13,635,000)$(9,742,000)$(4,363,000)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation412,000259,000123,000
Stock-based compensation601,000449,000200,000
Noncash lease expense324,000214,000106,000
Inventory write downs482,000351,000110,000
Changes in operating assets and liabilities:
Accounts receivable(3,411,000)913,0001,586,000
Inventories(10,224,000)(8,886,000)(3,210,000)
Other assets(118,000)(408,000)(567,000)
Accounts payable6,186,0002,064,0002,123,000
Accrued expenses(441,000)(350,000)(675,000)
Accrued interest–1,0001,000
Office leases payable(322,000)(211,000)(104,000)
Deferred revenue289,000116,000103,000
Customer deposits519,000(171,000)151,000
Net cash used in operating activities(19,338,000)(15,401,000)(4,416,000)
Cash flows from investing activities:
Purchases of equipment(644,000)(530,000)(238,000)
Net cash used in investing activities(644,000)(530,000)(238,000)
Cash flows from financing activities:
Proceeds from the issuance of common stock in registered direct offering, net of offering costs13,971,00013,971,00014,076,000
Proceeds from the issuance of common stock in public offering, net of offering costs1,602,0001,602,0001,602,000
Proceeds from revolving line of credit3,500,0003,500,000–
Net cash provided by financing activities19,073,00019,073,00015,678,000
Net change in cash(909,000)3,142,00011,024,000
Cash, beginning of period4,713,0004,713,0004,713,000
Cash, end of period$3,804,000$7,855,000$15,737,000
Supplemental Disclosures of Non-Cash Investing and Financing Activities:
Common stock issued for vested RSUs$9,700$–$–
Supplemental cash flow information:
Interest paid$86,000$33,000$2,000
As previously reportedRestatement adjustmentsReferenceAs restated
Cash flows from operating activities:
Net loss (a)(b)(d)(e)$(5,566,000)$(523,000)(a) (b) (d) (e)$(6,089,000)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation787,000–787,000
Stock-based compensation1,233,000–1,233,000
Fair value of warrants issued as debt discount cost92,000(92,000)(f)0
Amortization of debt issuance costs161,000–161,000
Non-cash lease expense448,000–448,000
Inventory write downs(a)13,000345,000(a)358,000
Changes in operating assets and liabilities:
Accounts receivable (b)(1,755,000)87,000(b)(1,668,000)
Inventories(a)(d)(1,191,000)(371,000)(a) (d)(1,562,000)
Other assets(81,000)92,000(f)11,000
Accounts payable(b)(d)(e)1,315,000207,000(b) (d) (e)1,522,000
Accrued expenses(e)464,000255,000(e)719,000
Accrued interest134,000–134,000
Office leases payable(476,000)–(476,000)
Deferred revenue212,000–212,000
Customer deposits(64,000)–(64,000)
Net cash used in operating activities(4,274,000)–(4,274,000)
Cash flows from investing activities:
Purchases of equipment(588,000)–(588,000)
Net cash used in investing activities(588,000)–(588,000)
Cash flows from financing activities:
Proceeds from stock option exercises and employee stock purchase plan exercises110,000–110,000
Proceeds from revolving line of credit52,820,000–52,820,000
Payment of revolving line of credit(49,087,000)–(49,087,000)
Payment of finance leases(110,000)–(110,000)
Net cash provided by financing activities3,733,000–3,733,000
Net change in cash(1,129,000)–(1,129,000)
Cash, beginning of period2,379,000–2,379,000
Cash, end of period$1,250,000$–$1,250,000
Supplemental Disclosures of Non-Cash Investing and Financing Activities:
Common stock issued for vested RSUs$222,000$–$222,000
Warrants issued in connection with borrowing agreements, recorded as debt issuance cost$–$92,000(f)$92,000
Supplemental cash flow information:
Interest paid$1,000,000$–$1,000,000
As previously reported · Restatement adjustments · Reference · As restated
Cash flows from operating activities:
Net loss(a)(b)(d)(e)$(2,926,000)$(158,000)(a) (b) (d) (e)$(3,084,000)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation523,000(92,000)(f)523,000
Stock-based compensation670,000–670,000
Fair value of warrants issued as debt discount cost(f)92,000(92,000)(f)–
Amortization of debt issuance costs134,000–134,000
Non-cash lease expense296,000–296,000
Inventory write downs(a)(2,000)235,000(a)233,000
Changes in operating assets and liabilities:
Accounts receivable (b)(3,930,000)4,000(b)(3,926,000)
Inventories(a)(d)715,000(344,000)(a) (d)371,000
Other assets(f)(157,000)92,000(f)(65,000)
Accounts payable(b)(d)(e)286,000203,000(b) (d) (e)489,000
Accrued expenses(e)109,00060,000(e)169,000
Accrued interest128,000–128,000
Office leases payable(312,000)–(312,000)
Deferred revenue179,000–179,000
Customer deposits150,000–150,000
Net cash used in operating activities(4,045,000)–(4,045,000)
Cash flows from investing activities:
Purchases of equipment(338,000)–(338,000)
Net cash used in investing activities(338,000)–(338,000)
Cash flows from financing activities:
Proceeds from revolving line of credit35,868,000–35,868,000
Payment of revolving line of credit(32,205,000)–(32,205,000)
Payment of finance leases(75,000)–(75,000)
Net cash provided by financing activities3,588,000–3,588,000
Net change in cash(795,000)–(795,000)
Cash, beginning of period2,379,000–2,379,000
Cash, end of period$1,584,000$–$1,584,000
Supplemental Disclosures of Non-Cash Investing and Financing Activities:
Common stock issued for vested RSUs$183,000$–$183,000
Warrants issued in connection with borrowing agreements, recorded as debt issuance cost (f)$-$92,000(f)$92,000
Supplemental cash flow information:
Interest paid$605,000$–$605,000
As previously reportedRestatement adjustmentsReferenceAs restated
Cash flows from operating activities:
Net loss(a)(b)$(2,112,000)$(76,000)(a) (b)$(2,188,000)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation261,000–261,000
Stock-based compensation276,000–276,000
Amortization of debt issuance costs81,000–81,000
Non-cash lease expense146,000–146,000
Inventory write downs(a)(3,000)116,000(a)113,000
Changes in operating assets and liabilities:
Accounts receivable (b)(2,050,000)10,000(b)(2,040,000)
Inventories(a)(496,000)(50,000)(a)(546,000)
Other assets(215,000)–(215,000)
Accounts payable330,000–330,000
Accrued expenses601,000–601,000
Accrued interest100,000–100,000
Office leases payable(152,000)–(152,000)
Deferred revenue205,000–205,000
Customer deposits(65,000)–(65,000)
Net cash used in operating activities(3,093,000)–(3,093,000)
Cash flows from investing activities:
Purchases of equipment(181,000)–(181,000)
Net cash used in investing activities(181,000)–(181,000)
Cash flows from financing activities:
Proceeds from the issuance of common stock in registered direct offering, net of offering costs
Proceeds from revolving line of credit18,055,000–18,055,000
Payment of revolving line of credit(15,981,000)–(15,981,000)
Payment of finance leases(40,000)–(40,000)
Net cash provided by financing activities2,034,000–2,034,000
Net change in cash(1,240,000)–(1,240,000)
Cash, beginning of period2,379,000–2,379,000
Cash, end of period$1,139,000$–$1,139,000
Supplemental cash flow information:
Interest paid$223,000$–$223,000
As previously reportedRestatement adjustmentsReferenceAs restated
Cash flows from operating activities:
Net loss(a)(d)$(5,265,000)$(278,000)(a) (d)$(5,543,000)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation647,000–647,000
Stock-based compensation539,000–539,000
Amortization of debt issuance costs445,000–445,000
Non-cash lease expense370,000–370,000
Inventory write downs(a)214,000(23,000)(a)191,000
Changes in operating assets and liabilities:–
Accounts receivable (b)(1,244,000)(28,000)(b)(1,272,000)
Inventories(a)(d)(4,911,000)301,000(a) (d)(4,610,000)
Other assets11,000–11,000
Accounts payable (b)4,182,00028,000(b)4,210,000
Accrued expenses395,000–395,000
Accrued interest2,000–2,000
Office leases payable(379,000)–(379,000)
Deferred revenue(163,000)–(163,000)
Customer deposits(40,000)–(40,000)
Net cash used in operating activities(5,197,000)–(5,197,000)
Cash flows from investing activities:
Purchases of equipment(753,000)–(753,000)
Proceeds from sale of fixed assets8,000–8,000
Net cash used in investing activities(745,000)–(745,000)
Cash flows from financing activities:
Proceeds from the issuance of common stock in public offering, net of offering costs697,000–697,000
Proceeds from revolving line of credit48,800,000–48,800,000
Payment of revolving line of credit(43,198,000)–(43,198,000)
Payment of finance leases(52,000)–(52,000)
Net cash provided by financing activities6,247,000–6,247,000
Net change in cash305,000–305,000
Cash, beginning of period485,000–485,000
Cash, end of period$790,000$–$790,000
Supplemental Disclosures of Non-Cash Investing and Financing Activities:
Initial right of use asset recognition$855,000$–$855,000
Common stock issued for vested RSUs$114,000$–$114,000
Supplemental cash flow information:
Interest paid$524,000$–$524,000
As previously reportedRestatement adjustmentsReferenceAs restated
Cash flows from operating activities:
Net loss(a)(d)$(3,820,000)$(236,000)(a) (d)$(4,056,000)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation371,000–371,000
Stock-based compensation304,000–304,000
Amortization of debt issuance costs368,000–368,000
Non-cash lease expense236,000–236,000
Inventory write downs(a)135,000(47,000)(a)88,000
Changes in operating assets and liabilities:
Accounts receivable (b)(1,858,000)(40,000)(b)(1,898,000)
Inventories(a)(d)(3,380,000)283,000(a) (d)(3,097,000)
Other assets(17,000)–(17,000)
Accounts payable (b)6,152,00040,000(b)6,192,000
Accrued expenses89,000–89,000
Office leases payable(244,000)–(244,000)
Deferred revenue(82,000)–(82,000)
Customer deposits(146,000)–(146,000)
Net cash used in operating activities(1,892,000)–(1,892,000)
Cash flows from investing activities:
Purchases of equipment(344,000)–(344,000)
Proceeds from sale of fixed assets8,000–8,000
Net cash used in investing activities(336,000)–(336,000)
Cash flows from financing activities:
Proceeds from revolving line of credit30,550,000–30,550,000
Payment of revolving line of credit(28,628,000)–(28,628,000)
Payment of finance leases(22,000)–(22,000)
Net cash provided by financing activities1,900,000–1,900,000
Net change in cash(328,000)–(328,000)
Cash, beginning of period485,000–485,000
Cash, end of period$157,000$–$157,000
Supplemental Disclosures of Non-Cash Investing and Financing Activities:
Initial right of use asset recognition$258,000$–$258,000
Common stock issued for vested RSUs$114,000$–$114,000
Supplemental cash flow information:
Interest paid$288,000$–$288,000
As previously reportedRestatement adjustmentsReferenceAs restated
Cash flows from operating activities:
Net loss(a)(d)$(2,139,000)$(121,000)(a) (d)$(2,260,000)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation172,000–172,000
Stock-based compensation95,000–95,000
Amortization of debt issuance costs229,000–229,000
Non-cash lease expense117,000–117,000
Inventory write downs(a)25,00018,000(a)43,000
Changes in operating assets and liabilities:
Accounts receivable(2,987,000)–(2,987,000)
Inventories(a)(d)(2,641,000)103,000(a) (d)(2,538,000)
Other assets(229,000)–(229,000)
Accounts payable6,860,000–6,860,000
Accrued expenses9,000–9,000
Accrued interest1,000–1,000
Office leases payable(120,000)–(120,000)
Deferred revenue184,000–184,000
Customer deposits(165,000)–(165,000)
Net cash used in operating activities(589,000)–(589,000)
Cash flows from investing activities:
Purchases of equipment(352,000)–(352,000)
Net cash used in investing activities(352,000)–(352,000)
Cash flows from financing activities:
Proceeds from revolving line of credit12,900,000–12,900,000
Payment of revolving line of credit(12,138,000)–(12,138,000)
Net cash provided by financing activities762,000–762,000
Net change in cash(179,000)–(179,000)
Cash, beginning of period485,000–485,000
Cash, end of period$306,000$–$306,000
Supplemental Disclosures of Non-Cash Investing and Financing Activities:
Initial right of use asset recognition$78,000$–$78,000
Common stock issued for vested RSUs$5,000$–$5,000
Supplemental cash flow information:
Interest paid$99,000$–$99,000
As previously reportedRestatement adjustmentsReferenceAs restated
Cash flows from operating activities:
Net loss(a)(d)$(12,956,000)$(679,000)(a) (d)$(13,635,000)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation412,000–412,000
Stock-based compensation601,000–601,000
Non-cash lease expense324,000–324,000
Inventory write downs(a)109,000373,000(a)482,000
Changes in operating assets and liabilities:
Accounts receivable(3,411,000)–(3,411,000)
Inventories(a)(d)(10,530,000)306,000(a) (d)(10,224,000)
Other assets(118,000)–(118,000)
Accounts payable6,186,000–6,186,000
Accrued expenses(441,000)–(441,000)
Office leases payable(322,000)–(322,000)
Deferred revenue289,000–289,000
Customer deposits519,000–519,000
Net cash used in operating activities(19,338,000)–(19,338,000)
Cash flows from investing activities:
Purchases of equipment(644,000)–(644,000)
Net cash used in investing activities(644,000)–(644,000)
Cash flows from financing activities:
Proceeds from the issuance of common stock in registered direct offering, net of offering costs13,971,000–13,971,000
Proceeds from the issuance of common stock in public offering, net of offering costs1,602,000–1,602,000
Proceeds from revolving line of credit3,500,000–3,500,000
Net cash provided by financing activities19,073,000–19,073,000
Net change in cash(909,000)–(909,000)
Cash, beginning of period4,713,000–4,713,000
Cash, end of period$3,804,000$–$3,804,000
Supplemental Disclosures of Non-Cash Investing and Financing Activities:
Common stock issued for vested RSUs$9,700$–$9,700
Supplemental cash flow information:
Interest paid$86,000$–$86,000
As previously reportedRestatement adjustmentsReferenceAs restated
Cash flows from operating activities:
Net loss(a)(d)$(9,207,000)$(535,000)(a) (d)$(9,742,000)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation259,000–259,000
Stock-based compensation449,000–449,000
Non-cash lease expense214,000–214,000
Inventory write downs(a)169,000182,000(a)351,000
Changes in operating assets and liabilities:
Accounts receivable913,000–913,000
Inventories(a)(d)(9,239,000)353,000(a) (d)(8,886,000)
Other assets(408,000)–(408,000)
Accounts payable2,064,000–2,064,000
Accrued expenses(350,000)–(350,000)
Accrued interest1,000–1,000
Office leases payable(211,000)–(211,000)
Deferred revenue116,000–116,000
Customer deposits(171,000)–(171,000)
Net cash used in operating activities(15,401,000)–(15,401,000)
Cash flows from investing activities:
Purchases of equipment(530,000)–(530,000)
Net cash used in investing activities(530,000)–(530,000)
Cash flows from financing activities:
Proceeds from the issuance of common stock in registered direct offering, net of offering costs13,971,00013,971,000
Proceeds from the issuance of common stock in public offering, net of offering costs1,602,000–1,602,000
Proceeds from revolving line of credit3,500,000–3,500,000
Net cash provided by financing activities19,073,000–19,073,000
Net change in cash3,142,000–3,142,000
Cash, beginning of period4,713,000–4,713,000
Cash, end of period$7,855,000$–$7,855,000
Supplemental cash flow information:
Interest paid$33,000$–$33,000
As previously reportedRestatement adjustmentsReferenceAs restated
Cash flows from operating activities:
Net loss(a)(d)$(4,130,000)$(233,000)(a) (d)$(4,363,000)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation123,000–123,000
Stock-based compensation200,000–200,000
Non-cash lease expense106,000–106,000
Inventory write downs(a)24,00086,000(a)110,000
Changes in operating assets and liabilities:
Accounts receivable1,586,000–1,586,000
Inventories(a)(d)(3,357,000)147,000(a) (d)(3,210,000)
Other assets(567,000)–(567,000)
Accounts payable2,123,000–2,123,000
Accrued expenses(675,000)–(675,000)
Accrued interest1,000–1,000
Office leases payable(104,000)–(104,000)
Deferred revenue103,000–103,000
Customer deposits151,000–151,000
Net cash used in operating activities(4,416,000)–(4,416,000)
Cash flows from investing activities:
Purchases of equipment(238,000)–(238,000)
Net cash used in investing activities(238,000)–(238,000)
Cash flows from financing activities:
Proceeds from the issuance of common stock in registered direct offering, net of offering costs14,076,000–14,076,000
Proceeds from the issuance of common stock in public offering, net of offering costs1,602,000–1,602,000
Net cash provided by financing activities15,678,000–15,678,000
Net change in cash11,024,000–11,024,000
Cash, beginning of period4,713,000–4,713,000
Cash, end of period$15,737,000$–$15,737,000
Supplemental cash flow information:
Interest paid$2,000$–$2,000
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.